THE CARDIORESPIRATORY AND METABOLIC TOXICITY OF ACUTE NAPHTHALENE AND PYRENE EXPOSURE IN ADULT ZEBRAFISH (DANIO RERIO): RELATIONSHIP TO ARYL HYDROCARBON RECEPTOR ACTIVATION. by Yeung, Chanel 1993-
 
 
THE CARDIORESPIRATORY AND METABOLIC TOXICITY OF 
ACUTE NAPHTHALENE AND PYRENE EXPOSURE IN ADULT 
ZEBRAFISH (DANIO RERIO): RELATIONSHIP TO ARYL 
HYDROCARBON RECEPTOR ACTIVATION. 
 
 
 
 
A Thesis Submitted to the College of 
Graduate and Postdoctoral Studies 
In Partial Fulfillment of the Requirements 
For the Degree of Master of Science 
In the Toxicology Graduate Program, 
University of Saskatchewan 
Saskatoon, Saskatchewan, Canada 
By 
 
  
  
  
Chanel Yeung  
 
 
© Copyright Chanel Yeung, April, 2019. All rights reserved.
i 
 
PERMISSION TO USE 
 
In presenting this thesis in partial fulfillment of the requirements for a Postgraduate 
degree from the University of Saskatchewan, I agree that the Libraries of this University may 
make it freely available for inspection. I further agree that permission for copying of this 
thesis in any manner, in whole or in part, for scholarly purposes may be granted by the 
professor or professors who supervised my thesis work or, in their absence, by the Head of 
the Department or the Dean of the College in which my thesis work was done. It is 
understood that any copying or publication or use of this thesis or parts thereof for financial 
gain shall not be allowed without my written permission. It is also understood that due 
recognition shall be given to me and to the University of Saskatchewan in any scholarly use 
which may be made of any material in my thesis. Requests for permission to copy or to make 
other uses of materials in this thesis in whole or part should be addressed to:   
Chair of the Toxicology Graduate Program 
Toxicology Centre 
University of Saskatchewan 
44 Campus Drive  
Saskatoon, Saskatchewan S7N 5B3  
 
Dean College of Graduate and Postdoctoral Studies 
University of Saskatchewan 
116 Thorvaldson Building, 110 Science Place 
Saskatoon, Saskatchewan  S7N 5C9 
Canada 
ii 
 
ABSTRACT 
 
Benzo-a-pyrene (BaP), a representative polycyclic aromatic hydrocarbon (PAH), 
causes adverse cardiorespiratory and metabolic effects in adult zebrafish (Danio rerio), 
while other petrogenic PAHs e.g. naphthalene (NAP) or pyrene (PYR), are not well 
characterized. To investigate the hypothesis that acute exposure (48h) to NAP and PYR 
causes sublethal cardiorespiratory and metabolic impairment similar to BaP, adult zebrafish 
were aqueously exposed to NAP (0, 37, 370, and 3700 µg/L) or PYR (0, 0.25, 2.5 and 25 µg/L). 
Both PAHs had no major effects on metabolic rate or swimming endurance. Cardiac effects 
of acute NAP exposure were to increase filling of the heart during diastole and increase 
stroke volume, while PYR lowered heart rate. Overall, both NAP and PYR tended to increase 
glycogen and triglyceride levels in heart, liver and skeletal muscle, along with increased 
mRNA expression of CS and HOAD (both rate-limiting enzymes). However, PYR caused 
hepatic HOAD expression to decrease. One potential mechanism of toxicity for NAP and PYR 
could be through AhR activation, agreeing with observations that CYP1A mRNA expression 
was increased in cardiac and skeletal muscle, but disagreeing with observed decrease in liver 
after NAP exposure. In contrast, PYR had no effect on CYP1A mRNA expression in any tissues 
examined. Both NAP and PYR tended to increase SOD and GSR mRNA in the three tissues 
examined, suggesting activation of the antioxidant response. NAP and PYR may exert toxicity 
through three different mechanisms that could be related or functionally independent: 1) 
AhR agonist, 2) increased expression of cytochrome P450 1A (CYP1A) and/or 3) increased 
oxidative stress. To investigate mechanisms of toxicity, acute aqueous exposures (48h) to 
NAP or PYR were conducted in adult zebrafish alone or in the presence of an AhR antagonist 
iii 
 
(CH-223191), CYP1A inhibitor (fluoranthene), or antioxidant scavenger (tempol). NAP or 
PYR alone failed to significantly alter cardiovascular function or most metabolic endpoint 
examined at the moderate exposure levels examined in this study. In contrast, co-exposure 
of each pharmacological antagonist with either PAH produced a number of effects that were 
not merely reversing the effects of the PAHs, but instead appeared to be independent of or 
distinct from the PAH effect by itself. In order determine response patterns and relationships 
among the end-points, principal components analysis (PCA) was performed. PCA revealed 
two components that explained 71% of the variance in the data using 17 of the end-points. 
The first component was the one that best distinguished NAP and PYR alone groups from 
controls. This component was positively correlated with GSR, SOD and HOAD in cardiac and 
skeletal muscle as well as muscle CYP1A and a higher ratio of atrial-ventricular rates. The 
second component distinguished among groups treated with the three inhibitors, being 
positively correlated to liver CYP1A, heart rate, ejection fraction and higher energy stores in 
cardiac and muscle tissues. In conclusion, both NAP and PYR alone appear to cause cardiac 
toxicity through arrhythmia associated with oxidative stress, while AhR inhibition, CYP1A 
inhibition and free radical scavenging all were associated with improved cardiac function 
and higher energy stores. These results provide support for a complex interaction between 
normal cardiac and metabolic control with oxidative stress and AhR signaling. 
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PREFACE 
 
The general format of this thesis is as chapters with manuscripts as separate 
chapters; thus, some duplication of material is expected. Chapter 1 of this thesis is a general 
introduction and literature review, while Chapter 4 is a general discussion with overall major 
conclusions. Chapter 2 and 3 are both manuscripts that will be submitted for publication in 
scientific journals. The first data chapter, Chapter 2 is an investigation of the acute 
cardiovascular and metabolic impairment of acute naphthalene and pyrene exposure in 
adult zebrafish, while Chapter 3 is an investigation of whether acute naphthalene and pyrene 
toxicity in adult zebrafish depends on the relative potency as aryl-hydrocarbon receptor 
agonists and cytochrome P450 inducers are indicative of relative toxicity or whether 
oxidative stress is a better indicator. These two chapters relate to each other because chapter 
two investigated the concentration-response relationship to cardiorespiratory and 
metabolic impairments of the naphthalene and pyrene and chapter three was determining 
their mechanism of toxicity 
1 
 
CHAPTER 1: GENERAL INTRODUCTION 
1.1 Introduction 
1.1.1 Overview 
Polycyclic aromatic hydrocarbons (PAHs) are organic compounds with two or more 
fused aromatic rings that are produced by the combustion of oil, coal, fossil fuels and as by-
products through incomplete combustion of organic matter at high temperatures. PAHs are 
naturally found in the environment, mainly due to forest fires, volcanic activities and in areas 
of bitumen deposits. However, PAHs found in the ambient environment are more often the 
result of anthropogenic mobilization of contaminants and processes e.g. petroleum spills and 
oil sands activities, with the latter being a major source of emission in Canada (Neff et al., 
2005). PAHs are ubiquitous in the aquatic environment worldwide and throughout Canada 
in biota, groundwater, lakes, rivers, sediments and soils (CCME, 2008) which results in 
toxicity to inhabiting species. Benzo-a-pyrene (BaP) has been heavily studied and is used as 
a representative PAH. BaP produces acute adverse effects in adult zebrafish (Danio rerio) on 
cardiovascular and respiratory function (Gerger & Weber, 2015). The PAHs of interest for 
this thesis, naphthalene (NAP) and pyrene (PYR), are both components of oil or bitumen and 
are released into the air from burning coal, oil or tobacco smoke (Neff et al., 2005). Like many 
other PAHs, they are listed on the US Environmental Protection Agency’s priority pollutant 
list, making them chemical pollutants regulated with national discharge standards (US EPA, 
2014). However, minimal research has been done with NAP and PYR examining acute adult 
toxicity. For this thesis, zebrafish will be used as a model freshwater species. 
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1.1.2 Polycyclic aromatic hydrocarbons (PAHs)  
PAHs are defined as having two or more aromatic rings. They are non-polar, 
hydrophobic compounds that generally have high melting and boiling points, low vapour 
pressures, low water solubility and do not ionize (CCME, 2008). Although they are abundant 
in the environment, the fate of PAHs is determined by chemical processes such as 
volatilization, photolysis, hydrolysis, microbial degradation and adsorption to sediments 
(Wolska et al., 2012). PAHs enter organisms, then some are thought to interact with the aryl 
hydrocarbon receptor (AhR) and induce pathogenic changes through three different 
mechanisms (Incardona et al., 2011). PAHs that bind to AhR activate an adaptive response 
where cytochrome P4501A monooxygenase (CYP1A) enzymes are induced for metabolism 
of the ligand. However, this metabolic activity often instead leads to bioactivation of the 
parent compound into reactive, toxic metabolites. Reactive quinone metabolites cause 
excess production of reactive oxygen species (ROS), with superoxide production each time 
the quinone cycles to a semi-quinone and back, thereby depleting glutathione (GSH) stores 
and leading to oxidative stress (Salvo et al., 2016; Stohs et al, 2002). Oxidative stress by itself 
can cause cytotoxicity and increases cancer risk (Nebert et al., 2004; Rengarajan et al., 2015). 
Species with a greater ability of inducing CYP1A enzymes have been reported to have an 
increase in susceptibility to toxicity (Incardona, 2017; Okey, 1990). Carcinogenic PAHs are 
activated by both CYPs and epoxide hydrolase into “K-region” epoxides, previously reported 
as the ultimate carcinogenic metabolite. However, diol epoxide metabolites of PAHs with 
space(s) between the aromatic rings, known as the “bay region”, are mutagenic, highly 
reactive towards DNA and thus are concluded to be the ultimate carcinogenic metabolites of 
BaP (Gelboin, 1980; Shimada & Fujii-Kuriyama, 2004). These diol epoxides form adducts by 
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reacting with DNA and affecting cell replication (Shimada & Fujii-Kuriyama, 2004). The 
degree of reactivity and mutagenicity is determined by the location of the “bay region”. PAH 
exposure in animal studies has also determined that activation of the ras oncogene can cause 
tumor induction (Ding et al., 2006). Most PAH mechanisms of action have been inferred from 
BaP, but not all PAHs may act in the same manner as BaP. Barron et al. (2004) studied the 
relative potency of PAHs as AhR agonists in fish relative to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD). Generally, they found that two and three ring unsubstituted PAHs, such as 
NAP, were largely inactive at the AhR in fish. In contrast, the highest potency PAHs had 4-6 
aromatic rings with an exposed bay region, similar to PYR. Thus, PYR will be studied in this 
thesis because it is predicted to act largely via AhR activation, but yet knowledge of its 
mechanism of toxicity is limited compared to that of BaP.  
1.1.2.1 Naphthalene  
The simplest PAH, NAP (𝐶10𝐻8), is a white, crystal solid consisting of two aromatic 
rings fused together. It has the highest vapour pressure of all the PAHs (US EPA, 1998). Due 
to its low molecular weight, it is easily removed by volatilization from aquatic environments; 
a process considered insignificant for PAHs with three of more aromatic rings (CCME, 2008). 
The estimated half-life of NAP ranges from 4.2 to 7.3 hours in surface waters (CCME, 2008). 
Thus, toxicity to the aquatic environment tends to occur immediately after an oil spill when 
volatile components such as NAP are present in high quantities rather than weathered crude 
oil (Incardona, 2017). NAP has a low solubility of 33.72 g/L in water at 25°C (Ran et al., 
2002), but solubility increases as temperature increases. This results in less than 10% of 
NAP settling into sediments through the association with organic matter and instead it tends 
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to undergo biodegradation or photolysis, depending on the water chemistry and 
concentration (USEPA, 2003).  
In addition to being a common component in crude oil and refined products 
containing PAHs, NAP is also a widely used commercially in mothballs, carbamate 
insecticides, surface-active agents, synthetic resins and in the production of phthalic 
anhydride (USEPA, 2003; Vuchetich et al., 1996). The majority of NAP in the environment is 
from direct release into the air, accounting for 90% of total discharge and only 2.7% is found 
in the terrestrial environment. Approximately 5% of NAP entering the environment is 
released into water primarily from coal tar production, distillation processes, oil seepage 
and spills directly into surface water (USEPA, 2003). Therefore, NAP has the potential of 
directly affecting inhabiting freshwater species.  
Kerr & Melton (1999) analyzed 48 different crude oils from around the world to 
determine the concentrations of priority PAHs within each oil. Despite the variability in the 
content of the PAHs from each site, NAP is present in the highest concentration in all 48 
samples, ranging anywhere between 1.2-3700 mg/kg oil and averaging 427 mg/kg oil.  The 
U.S. Geological Survey National Ambient Water Quality Assessment (NAWQA) program 
reviewed and analyzed water samples and found that detection frequencies and 
concentrations for drinking water wells to be relatively low; at 1 µg/L or lower (USEPA, 
2003). These drinking water levels fall into the range of concentrations of NAP found in the 
aquatic environment, being 0.4-70 µg/L, (CCME, 2008). 
Microsomal metabolism is initiated when NAP is converted into 1-naphathol and then 
1,2-dihydro-1,2-dihydroxynaphthalene (O’Brien et al., 1985). Through the process of 
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epoxidation, NAP is also converted into reactive metabolites; naphthalene 1,2-oxide and 
sulphate, glucuronide and GSH conjugates. Wilson et al. (1996) determined that GSH 
depletion and direct toxicity to human hepatic microsomes is caused by 1-naphthol, 1,2-
naphthoquinone and 1,4-naphthoquinone, and not by the primary metabolite, 1,2-epoxide. 
Cytotoxicity and genotoxicity of NAP is due to the formation of quinones from 1-naphthol, 
not from the formation of the primary metabolite, resulting in oxidative stress and ROS 
formation. NAP exposure has also been reported to cause increased DNA damage in the brain 
and liver of mice (Bagchi et al., 2000). In the same study, the tumor suppressor gene p53 was 
shown to play a role in NAP toxicity with the use of p53 deficient mice being more susceptible 
to NAP than the controls. The toxic effects induced by NAP is thought to be mediated by 
oxidative stress, the production of ROS, GSH oxidation to form oxidized GSH (GSSG) and DNA 
damage, particularly related to carcinogenicity and cytotoxicity (Matés, 2000; Vuchetich et 
al., 1996). The important information to note for this thesis is that NAP is a PAH that is 
thought to work through AhR-independent mechanisms, but whether these oxidative stress 
mechanisms are also relevant for acute sub-lethal toxicity in fish is not known.  
1.1.2.2 Pyrene 
PYR (𝐶16𝐻8) is larger than NAP, but the smallest of the peri-fused PAHs, and is a 
colorless solid consisting of 4 fused benzene rings. Besides occurring ubiquitously as a 
product of incomplete combustion, anthropogenic sources of PYR in the environment 
include automotive care products, laundry and dishwashing products, personal care 
products, water treatment products and relatively high quantities in coal tar (Douben, 2003). 
Major sources of PYR in aquatic environments are from petroleum spillage, atmospheric 
deposition, wastewaters, and surface-land runoff (Eisler, 1987). PYR originating from crude 
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oil is less abundant in aquatic environments than NAP, ranging from non-detectable limits 
to 9.2 mg/kg oil (Kerr & Melton, 1999). Thus, aquatic levels resulting from various inputs 
were only 0.025 µg/L in aquatic environments, as reported by CCME (2008). Volatilization 
and microbial degradation are not important degradation pathways for PYR in aquatic 
systems, while photodegradation is important for PYR (Suess, 1976). PYR has a solubility of 
0.134 mg/L (Ran et al., 2002) and a half-life greater than 8 weeks. Thus PYR is considered a 
persistent substance (CCME, 2008). 
Adult goldfish (Carassius auratus) exposed to PYR for one week and determined that 
PYR induces oxidative stress through ROS production in fish liver. After 24 hours of PYR 
exposure at acutely toxic levels, bioaccumulation in the liver has been reported to occur and 
maximum levels reached (Yin et al., 2014). The hydroxyl radical (•OH) is generated shortly 
after PYR exposure, increases significantly with the exposure period, and decreases until the 
end of measured exposure period (Yin et al., 2014). 
Zebrafish larvae exposed to PYR showed different defects at different developmental 
stages, such as anemia, mild pericardial edema, a minor dorsal curvature, peripheral 
vascular defects and neuronal cell death (Incardona et al., 2004; 2006). However, cardiac 
conduction does not appear to be affected (Incardona et al., 2004). The mechanism of toxicity 
of PYR-induced developmental deformities is proposed to be through changes in the hepatic 
antioxidant enzyme superoxide dismutase (SOD), glutathione-S-transferase (GST) and 
catalase activity (Incardona et al., 2005; 2004). All three enzymes activities reported to reach 
maximum levels within 48 hours and then gradually decreased until day 21 (end of the 
experiment) with continuing aqueous PYR exposure in larval Carassius auratus (Yin et al., 
2014). Production of GSSG followed the levels of antioxidant responsive genes, while GSH 
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levels were inversely related, with maximum increase and decrease, respectively at 48 hours 
after exposure (Yin et al., 2014). This was followed by a gradual return to normal throughout 
the remaining exposure period. These results indicate that PYR bioaccumulating in the liver 
resulted in redox cycling and the production of free radicals is as important mechanisms of 
PYR toxicity in goldfish liver.  It is noted that these defects are very similar to those described 
by the potent ligand for the AhR, TCDD. Therefore, it is likely that PYR also acts through the 
AhR (Incardona et al., 2005; 2004), but direct evidence for this is lacking. Furthermore, 
whether acute sub-lethal toxicity in fish is also caused by AhR activation and oxidative stress 
mechanisms is unknown.  
1.1.2.3 Toxic Concentrations for Pyrene & Naphthalene  
The estimated acute toxicity of the PAHs of interest to this thesis were identified by 
Neff et al (2005) in marine and freshwater invertebrates and fish. He reported octanol-water 
partition coefficient (Kow)-corrected acute LC50 values of 4780 µg/L and 61 µg/L for NAP and 
PYR respectively (see Table 1.1). Corrected chronic toxicity LC50 values were estimated to be 
970 µg NAP /L and 12 µg PYR/L (Table 1.1). While both acute and chronic toxicity 
concentrations are approximately three orders of magnitude higher than normal ambient 
environmental concentrations (Table 1), the levels of NAP and PYR approach these toxicity 
levels in the immediate vicinity of a recent aquatic oil spill (Aas et al., 2000). Moreover, these 
values are based on lethality, but relevant acute (24-48h) sub-lethal toxicity, such as 
cardiorespiratory or metabolic impairment could occur at much lower concentrations in 
fish. NAP levels in most crude oils are very high (Neff et al., 2005), thus despite the short half-
life, the potential for acute adult cardiorespiratory or metabolic toxicity is of concern. In 
contrast, the longer half-life of PYR combined with its lower threshold for lethality (Payan et 
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al., 2008) suggests it may also have potential to exert acute adult fish toxicity after an oil spill, 
but its potential for toxicity will continue over a longer time frame. 
Table 1.1. Summary of the average environmental concentrations (Government of Canada, 
Environment Canada, & Health Canada, 1993), estimated acute and chronic toxicity  levels 
(Neff et al., 2005), water concentrations sampled after an oil spill (Aas et al., 2000), 
environmental half-life (CCME, 1999), and water quality guideline values for the protection 
of aquatic life (CCME, 2008) of PAHs of interest. 
 
PAH Environmental 
concentrations 
(µg/L) 
Acute 
Toxicity 
(µg/L) 
Chronic 
Toxicity 
(µg/L) 
Water 
Concentration 
(µg/L) 
Environmental 
Half-Life (𝑡1/2) 
Canadian 
Water 
Guideline 
value 
(µg/L) 
NAP 0.0036 4780 970 0.764 4.2-7.3 hours 1.1 
PYR 0.0003 61 12 0.038 >8 weeks 0.025 
 
1.1.2.4 Cytochrome P4501A Monooxygenase and Aryl Hydrocarbon Receptor 
Induction of CYP450 associated enzymes in the liver have been associated with 
exposure to contaminants, especially CYP1A in the liver. It has been assumed that all PAH 
exposure in fish leads to a receptor-mediated induction of CYP1A gene expression (Folkerts 
et al., 2017), where the CYP1A enzymes have important functions in the biotransformation 
of PAH into reactive metabolites or in the detoxification process. AhR activation has been 
reported to increases the transcription and translation of CYP isozymes 1A, CYP1B1 (Nebert 
et al., 2000) and CYP1C1 which is exclusive to fish species (Wang et al., 2006). High affinity 
ligands for the AhR include a variety of anthropogenic and naturally occurring pollutants, 
such as TCDD and co-planar halogenated biphenyls. Teleosts have two AhR genes due to 
genome duplication, AhR1 and AhR2 (Hahn, 2002). AhR2 transcripts are more abundant, 
widely distributed, and have been reported as the only functional receptor to TCDD and 
halogenated biphenyls in fish species (Andreasen, 2002; Hahn, 2002). However, Incardona 
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et al. (2005) was able to demonstrate that both toxic and non-toxic PAHs induce CYP1A in 
zebrafish embryo through both AhR1 and AhR2. BaP and β-naphthoflavone (BNF) are 
moderately strong AhR agonists capable of causing similar cardiac deformities as strong 
binding ligands like TCDD (Clark et al., 2010; Gerger et al., 2014). Hepatic CYP1A is a common 
biomarker of AhR agonist exposure in zebrafish, but extrahepatic organs including the 
kidney, heart and gills also have a high amount of CYP1A activity during AhR agonist 
exposure (Sarasquete & Segner, 2000). However, there has long been a debate as to whether 
CYP1A is merely a marker of AhR agonist exposure or whether it is involved directly in 
mediating toxicity. Recently, it was reported that zebrafish embryos exposed to weak AhR 
agonists and simultaneously to an inhibitor of CYP1A activity show greater developmental 
cardiotoxicity (Van Tiem & Di Giulio, 2011). The suggested explanation was that CYP1A 
activity is necessary to detoxify the weak AhR agonist or that low-level CYP1A activity is 
needed for normal zebrafish cardiac development (Brown et al, 2014). It is unknown 
whether weak AhR agonists, when combined with a CYP1A inhibitor also alter 
cardiorespiratory or metabolic function in adult fish. 
1.1.3 Cardiac physiology in fish  
Zebrafish (Danio rerio) are a model indicator freshwater fish species used for aquatic 
toxicology. This is due to their well-studied physiology and fully sequenced genome, making 
molecular and biochemical studies easier than in other fish species (Briggs, 2002). The 
zebrafish cardiovascular system is fully functional approximately 24h post fertilization 
(Schwerte & Fritsche, 2003), thus allowing the measurement of heart rate and oxygen 
consumption at early life stages. The adult zebrafish heart is approximately 1mm in size, is 
located anterior of the body cavity, ventral to the esophagus and functions to pump 
10 
 
oxygenated blood throughout the body (Menke et al., 2011). The ventricle consists of 
numerous trabeculae, each having a compact outer layer of muscle and spongy inner layer. 
When the ventricle contracts, it generates high pressure which leads the blood through the 
ventriculobulbar valve into the bulbus arteriosus; a thick muscular layer of fibro-elastic 
tissue and smooth muscle fibers. The afferent branchial arterioles distribute blood from the 
ventral aorta to the gills (Menke et al., 2011). After circulating oxygenated blood to the 
peripheral tissues, deoxygenated venous blood will return to the heart and enter the sinus 
venosus, a thin collagenous connective tissue. The blood then moves passively into the 
atrium which has a thinner muscle than the ventricle. During ventricular diastole and during 
atrial contraction, the blood enters passively, then actively through the atrioventricular 
valve into the ventricle (Menke et al., 2011). Cardiac activity and blood flow throughout the 
body is determined by the metabolic demand, with cardiac output increasing in response to 
increasing oxygen demand caused by increased temperature, exercise, detoxification or 
increased metabolism (Claireaux & Davoodi, 2010; Pinsky, 2016). 
1.1.4 Respiration and metabolism in fish 
1.1.4.1 Respiration 
When water moves in a unilateral direction over the gill membranes, respiration is 
accomplished as water is moved through the mouth, into the buccal cavity, through the 
pharynx and over the gills (Menke et al., 2011). Adult zebrafish gills are responsible for 
oxygen uptake, gas exchange, ion and water balance, nitrogenous waste excretion, and acid-
base maintenance (Rombough, 2002). The operculum covering the opening in the gills drives 
water flow with the buccal chamber, located anterior to the gill, and the opercular chamber, 
posterior to the gills, through alternate expanding and contracting.  During swimming, water 
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flow is achieved through ram ventilation: water is forced through the pharynx, over the gills 
and out the opercular chamber and gill slits (Menke et al., 2011). Zebrafish gills consists of 
four bilateral gill arches which contain skeletal muscles and are supported by bony and 
cartilaginous tissue (Menke et al., 2011).  
1.1.4.2 Metabolism 
Lipoprotein lipase (LPL) is a water-soluble enzyme responsible for hydrolyzing 
triglycerides in lipoproteins into free fatty acids and 2-monoacylglycerol, which are released 
into the bloodstream for tissue utilization (Murray et al., 2010). Within tissues, LPL is also 
needed to mobilize fatty acids for catabolism if fat has been stored in the tissue. In adult 
mammals, LPL is most abundant in adipose, lactating mammary glands, heart and skeletal 
muscle tissues, but not in the liver (Mead et al., 2002). In contrast, fish have higher levels of 
LPL in the liver and muscle (Tocher, 2003). Free fatty acid molecules are catabolized in the 
process known as β-oxidation (López-Patiño et al., 2014). This process occurs within the 
mitochondria, producing acetyl-CoA, which then feeds into the citric acid cycle to produce 
ATP. The rate limiting enzyme, 3-hydroxacyl-CoA-dehydrogenase (HOAD), is responsible for 
the catalysis of acyl-CoA into acetyl-CoA (López-Patiño et al., 2014) and is commonly used as 
a biomarker of as β-oxidation capacity (McClelland et al., 2006).  
Zebrafish depend on the oxidation of acetate derived mainly from fatty acid 
metabolism to produce ATP rather than carbohydrate or protein metabolism (Rajotte & 
Couture, 2002). Aerobic organisms rely on the tricarboxylic acid (TCA) cycle, also known as 
the citric acid cycle or the Krebs cycle for ATP production (Goertzen et al., 2012; Rajotte & 
Couture, 2002). The TCA cycle is a series of enzyme-catalyzed chemical reactions to generate 
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energy. After glycolysis and pyruvate production, the TCA cycle starts with the methyl 
carbon of acetyl-CoA binding its methyl carbon to the carbonyl carbon of oxaloacetate, 
producing citrate (Rajotte & Couture, 2002). Citrate synthase (CS) is the rate limiting enzyme 
that catalyzes this step in aerobic energy production, being common to both fatty acid and 
glucose aerobic metabolism (Goertzen et al., 2012; Rajotte & Couture, 2002). Therefore, CS 
activity can be used as an index of aerobic metabolic activity.  
1.1.5 Swimming and metabolic rates in fish 
Swimming is the horizontal or vertical locomotion without specification for spatial 
position, orientation and velocity. Measuring oxygen consumption rate (𝑀𝑂2) and observing 
swim performance along with cardiac function in fish is important to determine fish fitness 
after sub-lethal toxicant exposure (Mager & Grosell, 2011). Swimming is essential to many 
fish behaviours such as predatory avoidance, reproduction and obtaining food. Therefore, 
negative effects on any of these behaviours would have a much greater effect than just the 
single organism alone. By measuring the critical swimming speed ( 𝑈𝑐𝑟𝑖𝑡 ; a measure of 
aerobic swimming capacity and swimming endurance), along with oxygen consumption rate, 
aerobic performance and metabolic capacity during exposure to a stressor (Thomas et al., 
2013). Standard metabolic rate (SMR) is the minimum metabolic rate in order for life to be 
sustained, while the active metabolic rate (AMR) is the metabolic rate at the maximum water 
velocity during a 𝑈𝑐𝑟𝑖𝑡 test (Brett, 1972; Gerger & Weber, 2015). Both are both important 
values to measure alone as indicators of metabolism, but also to calculate metabolic capacity. 
The ratio of  AMR/SMR gives factorial aerobic scope (F-AS), indicative of aerobic capacity 
(Gerger & Weber, 2015; Killen et al., 2007).  
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1.2 Acute versus chronic development PAH toxicity  
Acute (<24h) toxicity of PAHs to fish has historically been reported to causes reverse 
narcosis (Di Toro et al., 2000; French-McCay, 2002) due to PAHs partitioning across cell 
membranes of nervous tissues and disrupting the central nervous system (Barron et al., 
2004). However, embryonic exposure to sub-lethal concentrations resemble the symptoms 
of blue-sac disease, which is usually caused by exposure to planar halogenated aromatic 
compounds and several PAHs (Incardona et al., 2004). Acute (<24h) cardiotoxicity of three-
ring and larger PAHs in fish embryos (such as PYR) has been shown to selectively disrupt 
cardiac function, while having minimal effect on neuronal function. Moreover, PAHs do not 
immobilize embryos or render them insensitive to mechanosensory stimulation, all of which 
are requirements for narcosis (Incardona et al., 2004).  Thus, acute functional cardiotoxicity 
in larval fish is mediated by a mechanism other than narcosis, while the contribution to acute 
adult toxicity is unknown. Chronic (>96h) toxicity is much more specific and is usually 
correlated to PAH metabolite residues found within tissues (Aas et al., 2000). Mechanisms of 
actions are dependent on the chemical and physical properties of the PAH, therefore are 
predicted to differ between the extremely volatile NAP and the peri-fused PYR (Martin et al., 
2013). Based on our limited knowledge of NAP and PYR mechanisms of toxicity, acute adult 
cardiorespiratory and metabolic toxicity are likely to be mediated by differing mechanisms, 
but this must be confirmed with the work proposed in this thesis.  
1.2.1 How cardiac function is affected by PAHs 
Incardona et al. (2004) exposed zebrafish larvae acutely (<24h) with to a variety of 
PAHs, including NAP and PYR. Larvae exposed to 5µM PYR displayed mild pericardial edema, 
slight bradycardia, and severely reduced peripheral blood circulation in the head. Cell death 
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in the neural tube caused a less pronounced dorsal curvature, anemia, and peripheral 
vascular defects (Incardona et al., 2004). However, cardiac conduction was not affected by 
PYR (Incardona et al., 2004). In the same study, zebrafish larvae exposed to 78 µM NAP 
through static exposure had grossly normal anatomical features, however displayed mild 
bradycardia. Zhang et al., (2012) conducted a similar study with and found that low level 
PYR levels failed to alter the AhR1a, AhR1b, AhR2 and CYP1A expression. However, NKx2.5, 
a homeodomain transcription factor that has an essential role in development of the 
cardiovascular system, was downregulated (Zhang et al., 2012). 
When adult zebrafish were acutely (48h) aqueously exposed to BaP, cardiac output 
and stroke volume significantly decreased (Gerger & Weber, 2015). End diastolic and 
systolic volumes were also significantly decreased when adult zebrafish were acutely (48h) 
exposed to BaP, indicative of decreased filling in the ventricle, thereby leading to less blood 
being pumped by the heart. Ventricular heart rate, but not atrial contractile rate, significantly 
declined with BaP exposure, causing bradycardia. This is similar to that reported for 
embryos exposed to BaP (Huang et al., 2012; Incardona et al., 2011) and adult zebrafish 
exposed to BNF (Gerger et al., 2014). When ventricular contractile rate drops without a 
change in atrial rate, this is due to a conduction blockade through the atrioventricular node, 
an effect thought to be mediated through oxidative stress in mammals (Oudit et al., 2006). 
Current knowledge of cardiovascular effects of NAP and PYR in adult zebrafish are virtually 
absent, but if these compounds work via oxidative stress, they may mediate atrioventricular 
blockade and diminish cardiac output in adult fish, similar to that observed for BaP and BNF. 
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1.2.2 How respiration and metabolism are affected by PAHs 
Gerger & Weber (2015) found 𝑀𝑂2  of all zebrafish, regardless of treatment, 
significantly increased with increasing swim speeds. Zebrafish exposed to BaP had higher 
𝑀𝑂2 at a given swimming speed compared to controls (Gerger & Weber, 2015). Zebrafish 
embryos exposed to weathered crude oil consisting of PAH mixtures at sub-lethal 
concentrations impaired swimming performance and changed ventricular shape (Hicken et 
al., 2011). An investigation of the impacts of the Erika oil spill off the southern coast of 
Brittany, France, on sole (Solea solea) reported histomorphological alterations of the gill 
epithelium in 85% of fuel-exposed sole. At the highest dose, the secondary lamellae 
respiratory epithelium had thinned or completely disappearing in some fish, but no 
alteration of the primary lamellae was observed (Claireaux et al., 2004).  
TCDD has been demonstrated to affect CS mRNA expression in mice and humans 
(Gohlke et al., 2009). Moreover, TCDD is reported to increase triglyceride levels in tissue and 
reduce the ability to swim at high speeds in zebrafish (Marit & Weber, 2012). Glycogen, the 
storage form of glucose in animals, has been reported to have changed after NAP exposure 
in fish. Dangé (1986) found that tilapia exposed to sub-lethal concentrations of NAP caused 
a decrease in liver and muscle glycogen levels. The similar impact was observed when 
rainbow trout were also exposed to sub-lethal concentrations of NAP, resulting in a dose 
dependent decrease in a 6-hour period due to mobilization of glycogen (Tintos et al., 2006). 
Decreased glycogen after NAP exposure was attributed to enhanced use of glucose in the 
liver, either from glycogen stores or from the blood stream (Tintos et al., 2006). Thus, 
although some research has been done on the acute effects of PAHs on aerobic glycolysis in 
adult fish, relatively little is known about PAH-mediated effects on fatty acid mobilization 
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and fatty acid oxidation. Characterizing whether PAHs with different modes of action have 
differential acute effects on glycolysis and fatty acid metabolism in adult fish is a goal of this 
thesis. 
Adult zebrafish metabolism was significantly altered after acute (48h) exposure to 
BaP, with elevated SMR, no change in AMR and reduced factorial aerobic scope (F-AS) 
(Gerger & Weber, 2015). This is consistent with the impacts of the Erika oil spill on sole; no 
change in basal metabolic rate (BMR), but significant reduction in SMR (Claireaux et al., 
2004), In another study, AMR decreased 27% after exposure to resulting in a reduction on 
aerobic metabolic capacity, indicative of changes in the ability of fish to face environmental 
challenges (Davoodi & Claireaux, 2007). Aside these reports of respiratory and metabolic 
effects in adult fish acutely (24-48h) exposed to PAHs, they are limited to crude oil as a whole 
or BaP. PAHs other than BaP are a concern if they also alter adult fish metabolism after acute 
(24-48h) exposure, but is largely unknown and will be investigated in this thesis. 
1.2.3 How swimming is affected by PAHs 
Swimming performance is indirectly negatively affected by cardiac toxicity caused by 
crude oil, as reported by Hicken et al. (2011), who found an 18% decline in the aerobic 
performance (𝑈𝑐𝑟𝑖𝑡) in adult zebrafish. With increasing concentrations of PAHs exposure, 
swimming activity has been reported to decrease with increasing number of lethargic 
juvenile gilthead seabream (Sparus aurata) fish (Gonçalves et al., 2008). The fish behavioral 
responses to three PAHs, including PYR, caused 60-75% of fish to show no swimming activity 
at the highest dose (50µg/L) (Gonçalves et al., 2008). In contrast, adult zebrafish exposed to 
acutely (48h) to BaP had significantly increased COT (cost of transport), yet 𝑈𝑐𝑟𝑖𝑡 was not 
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significantly altered (Gerger & Weber, 2015). A decline in swimming performance has 
ecological relevance at the population level and thus must be further investigated. 
1.3 Unanswered questions/problems to be addressed with my research 
i. Does NAP and PYR cause cardiorespiratory and metabolic impairment after acute 
(48h) exposure in adult fish?  
ii. After 48-hour exposure, will the parent compound (or metabolite) be found 
within tissues and correlate to biological effect? 
iii. Will NAP and PYR affect energy stores of triglycerides and glycogen and/or levels 
of key metabolic enzymes? 
iv. Are NAP and PYR AhR agonists? Is CYP1A induction indicative of toxicity or is 
oxidative stress a better indicator? 
1.3.1 Rationale for experiments 
PAHs are pervasive contaminants whose toxicity to aquatic species is due to more 
than just BaP. While BaP is the representative PAH whose chemistry and mechanism of 
action are well known, it may differ from other important petrogenic PAHs, such as NAP and 
PYR. Both NAP and PYR have some ability be to AhR as agonists, however with much 
different binding affinities (Barron et al., 2004). It is assumed, yet not definitively proven, 
that NAP affinity for the AhR is significantly less than PYR. PAHs in weathered crude oils are 
developmentally cardiotoxic and show a strong correlation with AhR activation (Zhang et al., 
2012). In contrast, the mechanism of action of NAP and PYR, specifically on adult zebrafish 
cardiorespiratory and metabolic function is unclear. Additional investigation is needed into 
whether relative potency AhR agonist and CYP1A induction are indicative of relative toxicity 
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or whether oxidative stress is a better indicator.  This can be studied by inhibiting these three 
endpoints and looking at the overall effects on NAP and PYR exposure to zebrafish. Based on 
the literature, proposed mechanisms of action for NAP and PYR that will be investigated in 
this thesis are shown in Figure 1.1. 
 
 
 
Figure 1.1: Schematic representation of hypothesized mechanism of action during acute 
(48h) exposure of NAP and PYR to adult zebrafish. 
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1.4 Hypotheses 
i. Acute (48h) exposure to NAP and PYR will also cause cardiorespiratory and metabolic 
impairment in adult fish. 
ii. After 48-hour exposure, the parent compound metabolites will be found within 
tissues. 
iii. NAP and PYR will deplete energy stores of glycogen, but increase triglycerides with 
differential effects on LPL, HOAD and CS. 
iv. PYR, but not NAP, is a weak AhR agonist and will cause an increase in CYP1A gene 
expression.  
v. CYP1A expression increases stimulated via AhR will be independent of 
cardiovascular (atrioventricular conduction blockade, decreased cardiac output) and 
metabolic toxicity.  
vi. NAP and PYR will cause cardiorespiratory and metabolic toxicity through oxidative 
stress. 
1.5 Research Design 
1.5.1 Experiment 1 & 2: Basic characterization of acute NAP and PYR cardiorespiratory and 
metabolic toxicity in adult zebrafish 
The ubiquitous nature of PAHs found in the ambient environment is a cause for 
concern for freshwater aquatic species. Important petrogenic PAHs, such as NAP, found in 
high concentrations in crude oil, and PYR, which has a low threshold of toxicity, have had 
minimal research in comparison to the representative BaP. Therefore, the purpose of my 
research is to investigate the cardiorespiratory and metabolic impairment of NAP and PYR 
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to adult zebrafish, to resemble toxicity immediately after an oil spill. To characterize the 
concentration-response relationship of acute toxicity of NAP and PYR to adult zebrafish, 
high-resolution cardiovascular ultrasound and swim tunnel analysis examined the 
cardiorespiratory toxicity of NAP and PYR.  Quantifying the changes in energy stores content 
and determining the changes in mRNA levels of important metabolizing enzymes were used 
to characterize the tissue specific (heart, liver and skeletal muscle) changes in metabolism. 
Finally, tissue specific changes in mRNA levels of CYP1A and antioxidant enzymes were used 
to determine the toxicity of NAP and PYR to adult zebrafish.  
Experiments were performed in clean, dechlorinated, aerated municipal water with 
dissolved PAHs using static renewal conditions.  Adult zebrafish (0.3-0.8g) were randomly 
selected from holding tanks, placed in static aerated glass beakers (4 fish/1 L beaker) 
containing vehicle control (0.05% DMSO), 0.25, 2.5, 25 µg/L of PYR dissolved in 27±1°C 
water and PYR renewal at 24 hours for a total of 48-hour exposure. NAP test will be 
conducted exactly the same, using 3.7, 370, 3700 µg/L. The test concentrations were chosen 
on the basis of aquatic environment relevant concentrations (CCME, 1999) and the highest 
reported concentrations found in crude oil (Pampanin & Sydnes, 2013).  Post 48-hour 
exposure, half of the fish in each treatment groups (n=16/treatment) were subjected to the 
swim tunnel and the other half subjected to cardiac ultrasound (n = 16/treatment). Fish were 
dissected where the heart, liver and skeletal muscle were saved. Fish that were for 
triglyceride and glycogen analysis were only subjected to the cardiac ultrasound. The 
remaining dissected fish will be used for mRNA levels of CYP1A, CS, LPL, HOAD, GSR and 
SOD. Parent compound analysis of NAP and PYR were performed on a sub-set of remaining 
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fish not needed for other analyses from both swim testing and ultrasound using the whole 
carcass.  
1.5.2 Experiment 3: Pharmacological characterization of mechanisms of toxicity of acute NAP 
and PYR cardiorespiratory and metabolic toxicity in adult zebrafish 
Once the cardiorespiratory and metabolic toxicity of NAP and PYR was characterized, 
the mechanism of toxicity was determined using a threshold concentration for each PAH 
determined in the previous experiment. With the use of pharmacological inhibitors, adult 
zebrafish were then co-exposed with the threshold concentration of each PAH of interest. 
The most sensitive end-points from experiment 1 (swim tunnel analysis not measured), 
were repeated.  
From experiment 1 and 2, the threshold concentration of NAP and PYR exposure was 
chosen for our co-exposure. Adult zebrafish were co-exposed to each PAH (370 µg NAP/L 
AND 2.5 µg PYR/L) and 3 antagonistic treatments for 48 hours: 
• 3334 µg/L CH-223191 (Ko & Shin, 2012)   
• 500 µg/L fluoranthene (FL) (Brown et al., 2014) 
• 172 µg/L Tempol (4-hydroxy-TEMPOL) (Epperly et al., 2012) 
FL is a known CYP1A inhibitor (Wassenberg & Di Giulio, 2004), while Tempol is a known 
antioxidant scavenger for free radicals (Chatterjee et al., 2000). Inhibiting CYP1A activity, or 
detoxifying ROS which blocks the need for CYP1A, can determine if biotransformation of NAP 
or PYR into reactive metabolites causing oxidative stress is responsible for the toxic effects 
or if CYP1A aids in the detoxification process.  To determine if this process is independent of 
AhR binding, a potent AhR antagonist that does not stimulate AhR-dependent transcription 
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CH-223191 will be used (S. Kim et al., 2006). Comparing these three antagonist treatments 
will determine the mechanism of action NAP and PYR causing the expected 
cardiorespiratory and metabolic effects. Co-exposure to FL and CH-223191 are expected to 
have similar results. 
Naphthalene (NAP), Pyrene (PYR), dimethyl sulfoxide (DMSO), ethyl 3 
aminobenzoate methanesulfonate (MS-222) fluoranthene (FL), CH-223191 and tempol were 
all purchased from Sigma-Aldrich (Oakville, ON, Canada). The anesthesia, Aquacalm, will be 
purchased from Syndel Laboratories (Vancouver, BC, Canada). 
 
Summary of experiments 
• Experiment 1 – NAP exposure 
o 48-hours exposure 
o n = 32 fish 
o Treatments: 0 (0.05% DMSO), 37, 370, 3700 µg/L 
 
• Experiment 2 – PYR exposure 
o 48-hours exposure 
o n = 32 fish 
o Treatments: 0 (0.05% DMSO), 0.25, 2.5, 25 µg/L 
 
• Experiment 3 – NAP and PYR mechanism of action investigation 
o 48-hours exposure 
o n = 32 fish 
o Treatments: 
▪ Control: 0.05% DMSO 
▪ 370 µg/L NAP or 2.5 µg/L PYR 
▪ 500 µg/L FL + + 370 µg/L NAP or 2.5 µg/L PYR 
▪ 3334 µg/L CH-223191 + 370 µg/L NAP or 2.5 µg/L PYR 
▪ 172 µg/L Tempol + 370 µg/L NAP or 2.5 µg/L PYR  
 
 
23 
 
CHAPTER 2: THE CARDIORESPIRATORY AND METABOLIC 
TOXICITY OF ACUTE NAPHTHALENE VERSUS PYRENE 
EXPOSURE IN ADULT ZEBRAFISH (DANIO RERIO). 
 
2 Preface 
The research in this chapter was designed to address the acute cardiovascular and 
metabolic impairment of acute naphthalene and pyrene exposure in adult zebrafish. The 
author contributions to Chapter 2 of this thesis were as follows:  
Chanel Yeung (University of Saskatchewan) performed 100% of all animal experiments, 
collected, processed, and analyzed all samples, performed all statistical analyses, and drafted 
the manuscript. Lynn Weber (University of Saskatchewan) supervised, helped with study 
design, provided scientific input and guidance, and edited the manuscript. Chapter 2 is being 
prepared for submission to Comparative Biochemistry & Physiology, Part C: Toxicology & 
Pharmacology.  
2.1 Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) are organic compounds consisting or two or 
more aromatic rings that are found naturally in the environment from forest fires, volcanic 
activity and in areas of bitumen deposits. However, anthropogenic sources of PAHs also 
occur from incomplete combustion of organic matter at high temperatures, fossil fuel 
extraction, coal mining, oil spills and oil sands wastes (Neff et al., 2005). Abundant sources 
and continued input leads to ubiquitous PAH contamination in the aquatic environment 
resulting in toxicity to aquatic species (Jaward, 2012; CCME, 1999). Toxicity occurs for some 
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PAHs when they interact with the aryl hydrocarbon receptor (AhR), a ligand activated 
transcription factor known to mediate toxicological effects of many environmental 
pollutants (Gerger & Weber, 2015; Schmidt & Bradfield, 1996). The well characterized 
response to AhR activation is increased transcription/translation of phase one cytochrome 
P450 1A monooxygenase (CYP1A), which in turn causes production of reactive oxygen 
species and stimulation of the antioxidant system. Alternatively, some PAHs or their 
metabolites may cause oxidative stress in an AhR-independent manner (Guigal et al., 2000; 
Raha et al., 1995). The well-studied and abundant aquatic PAH contaminant, benzo-a-pyrene 
(BaP), is a known AhR agonist that biotransforms via CYP1A metabolism into reactive 
metabolites that are mutagenic, cytotoxic and produce oxidative stress (U.S. EPA., 2017). 
Important antioxidant enzymes, superoxide dismutase (SOD) (Kim & Lee, 1997; Miller & 
Ramos, 2001) and glutathione reductase (GSR; Miller & Ramos, 2001; Wells et al., 1997) have 
been shown to have protective against BaP embryotoxicity. 
Acute effects of exposure to complex PAH mixtures (e.g. crude oil) on metabolism have 
been studied in adult fish. Most studies report an increase in basal or standard metabolic 
rate (SMR) and no change or decrease in active metabolic rate (AMR) after acute PAH 
mixture exposure, leading to a fairly consistent finding of decreased aerobic scope (AS) 
(Davoodi & Claireaux, 2007; Gerger & Weber, 2015; Nelson et al., 2017). However, zebrafish 
chronically exposed to pyrolytic PAHs via ingestion found no significant changes in SMR, 
AMR or F-AS at both juvenile and adult life stages (Lucas et al., 2016). Juvenile chinook 
salmon fed a PAH-contaminated diet had a reduction in total body lipid and plasma 
triglycerides (Meador, 2006).  It has been reported that the potent AhR agonist, 2,3,7,8-
tetrachlorodibenzodioxin (TCDD), increases triglyceride levels in zebrafish (Marit & Weber, 
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2012). TCDD also alters the rate limiting enzyme in the citric acid cycle, citrate synthase (CS) 
mRNA expression in humans and mice (Gohlke et al., 2009). Sub-lethal concentrations of 
NAP caused a decrease in tilapia liver and muscle glycogen levels (Dangé, 1986) and rainbow 
trout liver (Tintos et al., 2008). Although some research has been done on the acute effects 
of PAHs on aerobic glycolysis in adult fish, relatively little is known about PAH-mediated 
effects on fatty acid mobilization and fatty acid oxidation. Characterizing whether PAHs with 
different modes of action have differential acute effects on glycolysis and fatty acid 
metabolism in adult fish is a goal of this thesis. 
Adequate energy reserves and metabolism directly affect normal growth, survival and 
reproduction in fish, but also have a strong influence on swimming and cardiovascular 
function (Davoodi & Claireaux, 2007; Tocher, 2003). Increased metabolic demand is well 
known to drive increases in cardiac output in fish (Farrell, 1991; Kopp et al., 2014; Nelson et 
al., 2017). Despite the fact that PAHs should therefore increase cardiac output, instead 
developmental exposure to petroleum contaminants and specifically BaP are well known to 
cause lethal cardiac deformities and cardiac dysfunction in fish embryos or larvae (Esbaugh 
et al., 2016; Hicken et al., 2011; Incardona et al., 2004, 2006, 2010). More recently, acute 
exposure to petroleum or BaP has been shown to exert cardiorespiratory and metabolic 
effects in adult fish (Guy Claireaux & Davoodi, 2010; Gerger & Weber, 2015). Specifically, 
acute BaP exposure in adult zebrafish has been reported to cause arrhythmia 
(atrioventricular conduction blockade) and increased metabolic demand (oxygen 
consumption) with decreased aerobic scope (Gerger & Weber, 2015). This is similar to the 
reported effects of acute exposure to PAH mixtures derived from crude oil or individual 
tricyclic PAHS. In these studies, PAH mixture exposure in various aquatic species 
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consistently produced arrhythmias, decreased heart rate and impaired contractility 
(Incardona et al., 2009; Incardona & Scholz, 2017; Sørhus et al., 2016). While BaP has been 
studied as a representative of all PAHs, other petrogenic PAHs such as naphthalene (NAP) 
and pyrene (PYR) are often more abundant in petrogenic contamination and are often 
present at high enough concentrations to be of environmental concern (Barron & Holder, 
2003; Neff et al., 2005). Previous studies have reported that low level PYR is cardiotoxic to 
zebrafish embryos, changing heart morphology (elongated ventricle, string-like morphology 
and edema) similar to that described for the potent AhR agonist TCDD (Incardona et al., 
2004; Zhang et al., 2012). Developmental PYR exposure caused altered cardiac function 
(elevated heart rate, but decreased end diastolic, end systolic, and stroke volumes) in larval 
fish, without a change in CYP1A mRNA expression (Zhang et al., 2012).  Conversely, 
developmental exposure of zebrafish larvae to the less potent PAH, NAP, induced mild 
bradycardia and edema, without the profound teratogenic effects on the heart (Incardona et 
al., 2004). This difference in developmental cardiotoxicity between BaP, NAP and PYR could 
be related to differences in affinity for the AhR (Barron et al., 2004), but could also be related 
to differences in mechanisms of toxicity. Moreover, whether these same differences in 
toxicity would be evident in adult fish acutely exposed to NAP or PYR compared to known 
BaP cardiorespiratory toxicity is unclear.  
Therefore, the overall objective of the present study was to investigate the acute (48h) 
cardiorespiratory and metabolic toxicity of aqueous exposure to NAP and PYR in adult 
zebrafish. NAP and PYR body burdens were measured using high performance liquid 
chromatography with fluorescence detection (HPLC-FD). After 48hr exposure, fish 
underwent high frequency cardiac ultrasound to measure cardiac function, or swim tunnel 
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respirometry to determine changes in swimming endurance, metabolic rate and aerobic 
capacity. Quantitative reverse transcription PCR (qRT-PCR) was then used to quantify mRNA 
levels of important metabolic enzymes (citrate synthase, CS; 3-hydroxacyl-CoA 
dehydrogenase, HOAD), markers of AhR activation (CYP1A), and genes known to be 
responsive to oxidative stress (GSR and SOD) in heart, liver and skeletal muscle. Finally, 
changes in triglyceride and glycogen levels were measured in the same tissues as indicators 
of energy storage. 
2.2 Materials and Methods 
2.2.1 Chemicals 
 Naphthalene (NAP), pyrene (PYR), dimethyl sulfoxide (DMSO), and ethyl 3-
aminobenzoate methanesulfonate (MS-222), dichloromethane, acetone, acetonitrile, 
triglyceride and glycogen kits, were all purchased from Sigma-Aldrich (Oakville, ON, 
Canada).   
2.2.2 Test species 
Adult zebrafish were obtained from university colonies and acclimated in 30-L 
holding tanks with particulate, charcoal and ammonia biofilters for a minimum of two weeks 
prior to experiments. Zebrafish were kept on a 14-hour light and 10-hour dark photoperiod. 
Clean, dechlorinated, aerated municipal water was maintained at 27 ± 1 °C with 80% water 
change performed weekly during basic maintenance. Zebrafish were fed twice a day with 
Nutrafin basic flake food (Hagen Inc., Montreal, QC, Canada), with the exception of the last 
24h of exposure or during swim performance or cardiac function testing (Gerger et al., 2014; 
Gerger & Weber, 2015). Experiments were conducted according to procedures approved by 
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the University of Saskatchewan Animal Care and Use committee according to the Canadian 
Council on Animal Care guidelines. 
2.2.3 Aqueous exposure 
Adult zebrafish (0.3-0.8g) were randomly selected from holding tanks, placed in 
aerated 2-L glass beakers (4 fish/1 L exposure solution) containing vehicle control (0.05% 
DMSO), PYR (0.25, 2.5, or 25 µg/L) or NAP (37, 370, 3700 µg/L) in 27±1°C water for 48-hour 
exposure (static with renewal at 24-hr). Test concentrations were chosen on the basis of 
water quality guidelines for the protection of aquatic life (CCME, 1999) and the highest 
reported concentrations found in crude oil (Pampanin & Sydnes, 2013).  After 48-hour 
exposure, half of the fish in each treatment groups (n=16/treatment) were subjected to swim 
tunnel and the other half were used for cardiac ultrasound (n = 16/treatment). After 
ultrasound, heart, liver and skeletal muscle from a portion of the zebrafish were stored at -
80C for triglyceride and glycogen analyses. The heart, liver and skeletal muscle from a 
portion of the zebrafish after swim tunnel testing were stored at -80C in RNAlater until use 
for mRNA levels of CYP1A, CS, HOAD, GSR and SOD. All remaining zebrafish carcasses minus 
the gastrointestinal tract and head after either ultrasound or swim tunnel testing were used 
for PYR and NAP parent compound analysis and frozen at -80C in ethanol-washed foil until 
extraction for HPLC analyses. 
2.2.4 Total PAH body burden analysis 
  Whole fish carcasses were freeze dried using a Virtis Genesis 25ES freeze drier, and 
stored at -20 °C until extraction. Extractions were carried out using a Dionex ASE 3—
Accelerated Solvent extractor (ASE). Samples were weighed and placed into methanol-
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rinsed 1ml stainless-steel cells, fitted with a cellulose filter at both ends prior being sealed 
and situated in the carousel of ASE 200 system. The conditions were as follows: oven 
temperature of 125 °C with a 6 min heat–up time with a pressure of 1500 psi and two static 
cycles with a static time of 5 min. Samples were purged using pressurized nitrogen for 1 min 
with a flush volume of 10%. The solvent mixture used consisted of 1:1 
dichloromethane:acetone. 
 Following ASE extraction, samples were evaporated to near dryness under a stream 
of nitrogen and then re-suspended in 1 mL acetonitrile. ASE-extracted samples or exposure 
water samples were then glass syringe-filtered through Whatman GMF 0.45 µM filters into 
labeled 2 mL amber vials. An Agilent 1260 infinity HPLC-FD was then used to analyze NAP 
and PYR parent compound concentrations according to the Agilent method (Volk & 
Gratzfeld-Huesgen, 2011) with some modifications. An aliquot of 10 µL was injected into an 
Agilent PAH pursuit column maintained at 25 °C. The run time was set for 25 min with a 
solvent flow rate of 1.5 mL/min starting at a gradient of 60:40 acetonitrile:water and 
gradually increasing to 95:5 acetonitrile:water by 20 min. NAP eluted at ~3.5 min with a 
constant excitation wavelength of 260nm and an emission wavelength of 350 nm. PYR eluted 
at ~7.5 min with a constant excitation wavelength of 260 nm and an emission wavelength of 
410 nm. Total NAP and PYR masses were calculated for extracted carcass samples by 
comparing to peak height of PAH standards at different concentrations. Recovery of NAP and 
PYR from blank fish samples spiked with a known amount of standard was 111 ± 12% and 
84 ± 2.9% (n=5-6 independent spike/recovery samples for each), respectively.  
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2.2.5 In Vivo high frequency cardiovascular ultrasound 
After 48hr exposure, physiological changes to cardiac function were measured using 
a VEVO 3100 high frequency ultrasound machine (VisualSonics, Markham, ON Canada) 
equipped with B-mode imaging, pulsed-wave Doppler and colour flow Doppler according to 
methods adapted from rodents (VisualSonics, 2008) and previously described in zebrafish 
(Gerger et al., 2014; Gerger & Weber, 2015). Zebrafish were anesthetized with Aquacalm (20 
mg/L; Oakville, ON, Canada) in clean aerated, dechlorinated municipal water in a grooved 
holding dish, ventral side up, prior to ultrasonography and anesthesia is maintained 
throughout. Using a recirculating water bath with aerated anesthetic water, temperature 
was maintained at 27 ± 0.5 C (the same as housing temperature) to prevent temperature-
induced effects on cardiac function.  
The short and long-axis views of the ventricle were obtained using an MX 700 
scanhead (30-70 MHz; resolution to 30 µm) in B-mode. Simpson’s rule of disks calculated 
ventricular volume (Mercier et al., 1982; VisualSonics, 2008). The ventricle volume is the 
sum of the cylindrical disks plus an apical bullet-shaped disk. Because zebrafish do not have 
a hollow ventricular chamber like mammals do, the cross-sectional areas using traces of the 
outer edges of the ventricle were measured (A1 – A3) at three different levels of the ventricle 
in the short axis view. The height of each ventricle disk was then calculated by measuring 
the ventricular length (L) in the long axis view and dividing by the number of short axis views 
(h=L/3). Volume was calculated using an average of at least three different measurements 
in an individual fish during end-systole and during end-diastole for each measurement. 
𝑉 = (𝐴1 + 𝐴2)ℎ + [(
𝐴3ℎ
2
) + (
𝜋
6ℎ3
)] 
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(Mercier et al., 1982) 
Stroke volume (𝑉𝑠) for each fish was calculated by subtracting end-diastolic volume 
from end-systolic volume. Ventricular and atrial contractile rates were calculated by 
counting individual chamber contractions in 5 second B-mode ultrasound video loops, then 
converting to beats per minute (BPM). Ventricular heart rate (𝑓𝐻) multiplied by 𝑉𝑠 was used 
to calculate cardiac output (Q).  
𝑄 =  𝑉𝑠 ∗  𝑓𝐻 
Atrioventricular (AV) ratio was used as a measure of the efficiency of electrical 
excitation from the atrium to the ventricle via the atrioventricular (AV) node by dividing the 
atrial contractile rate by ventricular contractile rate for each individual fish. This value 
should equal 1.0 if cardiac electrical conduction is ideal. 
𝐴𝑉 𝑟𝑎𝑡𝑖𝑜 =  
𝐴𝑡𝑟𝑖𝑎𝑙 𝑓𝐻 
𝑉𝑒𝑛𝑡𝑟𝑖𝑐𝑢𝑙𝑎𝑟 𝑓𝐻
 
2.2.6 Swimming performance and oxygen consumption 
After 48 hour exposure, swim testing was conducted using a 170 mL swim tunnel 
respirometer (Loligo Systems, Tjele, Denmark). Fish were swim-tested in clean, 
dechlorinated, aerated municipal water, kept at 28° C by a 20-L recirculating water bath 
(VWR International, Mississauga, ON, Canada). The swim tunnel was submerged in the 20-L 
buffer tank and the water velocities calibrated using constant temperature anemometry 
according to the Loligo System instructions (Gerger et al., 2014; Gerger & Weber, 2015). 
Oxygen consumption rate was calculated using AutoRespTM 1 software (Loligo Systems, 
Denmark) during each speed increment of the swimming performance trial for each fish. 
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Prior to testing, fish were placed into the swim tunnel for 120 minutes acclimation at 0.02 
m/s and then a step-wise increase in the water velocity (0.077m/s (𝑈𝑖𝑖)) every 20 minutes 
(𝑇𝑖𝑖 ) until the fish fatigued (refused to swim).  𝑈𝑐𝑟𝑖𝑡  was calculated using the following 
equation (Brett, 1972): 
𝑈𝑐𝑟𝑖𝑡 =  𝑈𝑖 + [𝑈𝑖𝑖 (
𝑇𝑖
𝑇𝑖𝑖
)] 
𝑈𝑖= highest swimming velocity maintained during entire time interval 
𝑇𝑖 = time elapsed at fatigue velocity 
To account for the variation in fish size, 𝑈𝑐𝑟𝑖𝑡 values were converted from m/s to body 
lengths/s.  
Within each 20-minute swim velocity increment, oxygen consumption was measured 
twice, with a 1-minute flush and a 4-minute re-acclimation time between each measurement. 
After this, dissolved oxygen in the chamber water was measured for 5 minutes or until 
oxygen saturation fell to 90%. Oxygen consumption was calculated for each swim velocity. 
AMR for each fish was determined at the maximum swimming velocity prior to the fish 
fatiguing during the 𝑈𝑐𝑟𝑖𝑡 test. SMR was calculated by plotting oxygen consumption (m/s) 
against swimming speed using a non-linear fit and extrapolating the oxygen 
consumption  (𝑀𝑂2 ) at zero water velocity (Gerger et al., 2014; Thomas et al., 2013). 
Factorial aerobic scope (F-AS) was calculated as AMR/SMR (Gerger & Weber, 2015). Cost of 
transport (J/g/m) was calculated by multiplying 𝑀𝑂2 (mg 𝑂2/g/s) by an oxycaloric value of 
14.1 J/mg 𝑂2 and then dividing by the corresponding swimming speed (m/s) (Gerger & 
Weber, 2015; Thomas et al., 2013).     
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2.2.7 Determination of triglyceride and glycogen tissue stores 
Frozen hearts (2 hearts pooled to create one sample), liver (2 livers pooled to create 
one sample) and skeletal muscle (measured from individual fish) samples were weighed, 
homogenized in 0.2M sodium citrate, immediately heated for 5 min at 100C, then stored at 
-80C until assessment for triglyceride and glycogen levels. Briefly, triglycerides were 
determined using a kit based on a lipase and glycerol kinase colorimetric assay, which has 
been previously validated for measuring triglycerides in whole fish homogenates in our 
laboratory (Weber et al., 2003) and glycerol used as a standard. Glycogen was analyzed using 
an amylase and glucose oxidase-based colorimetric assay and purified Type IX bovine liver 
glycogen as a standard, as previously described in our group (Weber et al., 2008).  
2.2.8 Gene expression analysis – Real time qRT-PCR  
Quantitative qRT-PCR in zebrafish heart (2 heart pooled/sample), liver (2 liver 
pooled/sample) and skeletal muscle (one sample/fish) was examined for three classes of 
genes in zebrafish tissue using methods previously described in Bugiak & Weber (2009). As 
an indication of AhR activation, CYP1A mRNA transcript abundance was measured 
(Sarasquete & Segner, 2000). To determine the effects on metabolism, mRNA levels of rate 
limiting enzymes for oxidative metabolism, CS, or fatty acid oxidation, HOAD, were analyzed 
(Rajotte & Couture, 2002). Antioxidant responsive genes were also quantified using GSR and 
SOD mRNA transcript abundance (Cossu et al., 1997). Total RNA was extracted from frozen 
tissues with TRIzol (Life Technologies Burlington, ON, Canada) according to manufacturer 
specifications. A NanoDrop apparatus and software (Thermo Fisher Scientific, Waltham, MA, 
USA) was used to assess the purity and quantity of mRNA. Samples were reverse transcribed 
34 
 
into cDNA from total RNA with superscript II reverse transcriptase (iScript, Invitrogen, 
(Quanta Biosciences, Maryland, USA) and oligo (dT) primers using the cDNA synthesis kits 
(BioRad Mississauga, ON, Canada). Chromo4 Multi-Color Real-Time PCR detection system 
(Biorad, Mississauga, ON, Canada) was used for qRT-PCR. Glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) was used as a housekeeping gene and its expression determined 
for each run of a gene. Each sample was run in at least 3 different dilution for each primer 
pair along with the housekeeping gene to generate efficiency curves. The method of analysis 
used to represent the relative expression levels was calculated using CT, where the 
amount of the gene of interest was normalized to the amount of G3PDH in that sample as 
well as to the mean value for the control group and data expressed as fold change from 
control (Bugiak & Weber, 2009).  
Table 2. 1. Primer sequences for cDNA targets, GenBank accession numbers, target genes 
and their efficiencies that were used for real time qRT-PCR. (Liu et al., 2013; McClelland et 
al., 2006; Mccurley & Callard, 2008; Tiedke et al., 2013; Uren-Webster et al., 2010).  
Gene Primer Sequence (5’-3’) Accession 
number 
Efficiency 
(%) 
CYP1A 
 
Forward GCATTACGATACGTTCGATAAGGAC NM131879 114.0 
Reverse GCTCCGAATAGGTCATTGACGAT 
G3PDH Forward AGCACTGTTCATGCCATCAC NM213094 99.5 
Reverse TACTTTGCCTACAGCCTTGG 
CS Forward AGCGCTGCTATGAATGGTCT BC045362 93.3 
Reverse CTGAGGAAGACAGACCCTCG 
HOAD Forward CCACAGGACATTCAGTGGTG ZGI TC279717 
 
93.7 
Reverse GTCAGTGCCATGAACGACAG 
GSR Forward ACAGTCAGTGAGGATGATGTGCCAG NM001020554 97.0 
Reverse TAGACCCAAGAGTGGAAAGAATACCAGC 
SOD Forward TATGCAGCTTCATCACAGCAAGCA NM199976 100.0 
Reverse GGTTGTCACATCACCCTTGGCC 
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CYP1A = cytochrome P450 1A; G3PDH = Glyceraldehyde-3-phosphate dehydrogenase; CS = 
citrate synthase; HOAD = 3-hydroxacyl-CoA dehydrogenase; GSR = glutathione reductase; 
SOD = superoxide dismutase 
 
2.2.9 Statistical analysis  
One-way analysis of variance (ANOVA) followed by Fisher’s least significant difference 
(LSD) post hoc tests were used to determine significant difference among treatment groups 
for majority of the endpoints measured.  For oxygen consumption (𝑀𝑂2)  and cost of 
transport (COT), data was analyzed using a 2-way repeated measures (with swim speed and 
treatment as factors) followed by Fisher’s LSD post hoc test. All statistical analyses were 
carried out using SPSS Statistics v19.0 (IBM Corporation, Armonk, NY) and all results are 
presented as mean ± standard error of the mean (SEM). A p<0.05 was considered statistically 
significant. 
2.3 Results 
2.3.1 Zebrafish NAP and PYR body burdens 
Body burdens for adult zebrafish following 48h aqueous exposure to NAP or PYR are 
shown in Fig 2.1. Exposure of adult zebrafish to nominal concentrations of 0, 37, 370, 3700 
µg/L NAP for 48 hours resulted in body burdens that ranged from 1.36 ng/g in control to 
1.44 ng/g in NAP treatment groups (Fig 2.1 left panel). However, there were no significant 
differences in parent NAP body burdens between exposure groups relative to solvent 
control. Similarly, exposure of adult zebrafish to nominal concentrations of 0, 0.25, 2.5 and 
25 µg/L PYR for 48 hours resulted in body burdens that ranged from 8.89 ng/g in control to 
6.84 ng/g in exposed fish (Fig 2.1 right panel) with no significant difference among groups.  
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Figure 2. 1: Parent compound body burden (ng/g, dry mass) after 48-hour aqueous 
exposure to naphthalene (left; low = 37, med = 370, high = 3700 µg/L), pyrene (right; low = 
0.25, med = 2.5, high = 25 µg/L) or solvent control in adult zebrafish. Parent compound was 
measured using high pressure liquid chromatography with fluorescence detection. Data are 
mean ± SEM of n = 5-6 fish/group. No significant differences were detected for body 
burdens in separate one-way ANOVA analyses for naphthalene (NAP) and pyrene (PYR).  
 
2.3.2 Mortalities and morphometrics 
Following 48-hour aqueous exposure to either NAP or PYR, there were no statistically 
significant differences in body mass, body length or condition factor among exposure groups 
(Table 2.2). Only one mortality, in the 370 µg NAP/L exposure group, occurred during the 
duration of the entire experiment, resulting in no statistically significant differences among 
groups in mortalities.  
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Table 2. 2. Mortalities and morphometrics of adult zebrafish aqueously exposed to solvent 
control, naphthalene or pyrene for 48 h.  
 
Nominal PAH 
Concentration 
Mortalities 
(%) 
Body Weight 
(g) 
Body Length 
(cm) 
Condition 
Factor (K) 
Naphthalene 
Control 0 0.37 ± 0.02 3.04 ± 0.06 1.33 ± 0.07 
37 µg/L 0 0.36 ± 0.02 2.98 ± 0.03 1.38 ± 0.05 
370 µg/L 3.1 ± 3.6 0.37 ± 0.02 2.95 ± 0.06 1.46 ± 0.10 
3700 µg/L 0 0.36 ± 0.01 2.98 ± 0.06 1.43 ± 0.09 
Pyrene 
Control 0 0.37 ± 0.02 3.04 ± 0.06 1.33 ± 0.07 
0.25 µg/L 0 0.34 ± 0.02 2.95 ± 0.04 1.33 ± 0.06 
2.5 µg/L 0 0.37 ± 0.02 3.00 ± 0.06 1.37 ± 0.07 
25 µg/L 0 0.39 ± 0.02 3.01 ± 0.06 1.51 ± 0.14 
Data are mean ± SEM with n = 30-32/group for morphometrics; n=4 replicates/group for 
mortalities. Condition factor (K) = (weight (100/length3). No significant treatment effects 
were detected in separate one-way ANOVA analyses.  
 
2.3.3 Critical swimming speed and metabolic rates 
Oxygen consumption, indicated by 𝑀𝑂2 ,  increased in all control, NAP- and PYR-
exposed zebrafish with increasing swim speed (Figure 2.2A, 2.2B). Despite the fact that both 
control groups tended to have the lowest 𝑀𝑂2, no significant effect of PAH treatment was 
detected on 𝑀𝑂2. However, some of the treatment effect at higher swim speed is likely to 
have been masked because the number of fish declines as the swim tunnel test progressed 
to higher speeds due to fatigue. Only the lowest three swim speeds can be reliably compared 
since these have the full sample size of fish still swimming in each group. Overall, COT of all 
groups decreased as swim speed increased, regardless to exposure concentration to either 
NAP or PYR (Figure 2.2C, 2.2.D). Similar to 𝑀𝑂2 , there were no significant effects of 
treatment on COT.  Finally, neither NAP nor PYR significantly altered 𝑈𝑐𝑟𝑖𝑡 (Figure 2.3). 
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Figure 2. 2: Oxygen consumption rates (𝑀𝑂2) (A, B) and cost of transport (COT) (C, D) as a 
function of swimming speed in adult zebrafish following aqueous exposure to naphthalene 
(left), pyrene (right) or solvent control for 48 hours. Data are mean ± SEM of n = 14-16 
fish/group. *p < 0.05 in Fisher’s LSD after two-way ANOVA with swim speed and treatment 
as a factor. No significant differences were detected on (𝑀𝑂2) and (COT) in separate two-
way ANOVA analyses (speed and treatment as factors) for naphthalene (NAP) and pyrene 
(PYR).  Exact p-values for both factors are shown in each graph. No significant interactions 
were found between swimming speed and treatment. 
 
𝑀𝑂2  of all treatment groups significantly increased with increasing swim speed, 
including the control group (Figure 2.2). However, metabolic capacities in adult zebrafish 
after 48 hour of aqueous NAP or PYR exposure showed minimal change compared to control. 
Standard metabolic rate (SMR) remained statistically unchanged across all exposure 
concentrations for both NAP and PYR (Figure 2.4A). In contrast, active metabolic rate (AMR) 
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was significantly greater in zebrafish exposed to 0.25 µg PYR/L compared to corresponding 
controls (Figure 2.4B), while zebrafish in all other PYR exposures and all NAP exposures 
were not significantly different from control. Despite this significant change in the 0.25 µg 
PYR/L AMR, F-AS of all NAP and PYR-treated groups did not differ significantly from control 
(Figure 2.4C). COT of all treatment groups tended to decrease with increasing swim speed, 
however this was not significantly different from the control group.  
 
Figure 2. 3: Critical swimming speed (𝑈𝑐𝑟𝑖𝑡) of adult zebrafish following aqueous exposure 
to naphthalene (left; NAP; low = 37, med = 370, high = 3700 µg/L), pyrene (right; PYR; low 
= 0.25, med = 2.5, high = 25 µg/L) or solvent control for 48 hours. Data are mean ± SEM of n 
= 14-16 fish/group. No significant differences among groups were observed using Fisher’s 
LSD after one-way ANOVA. 
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Figure 2. 4: Standard metabolic rate (SMR) (A), active metabolic rate (AMR) (B) and 
factorial aerobic scope (F-AS) (C) of adult zebrafish following aqueous exposure to 
naphthalene (left; NAP; low = 37, med = 370, high = 3700 µg/L), pyrene (right; PYR; low = 
0.25, med = 2.5, high = 25 µg/L) or solvent control for 48 hours. Data are mean ± SEM of n = 
14-16 fish/group. *p < 0.05 in Fisher’s LSD after one-way ANOVA compared to the 
corresponding control group.  
 
2.3.4 Cardiac function 
B-mode echocardiograms in long and short axes of the zebrafish heart were used to 
measure ventricular end diastolic volume (EDV), end systolic volume (ESV), stroke volume 
(Vs) and ejection fraction in zebrafish after 48-hour exposure to NAP, PYR or solvent control 
(Figure 2.5A-D). In the zebrafish exposed to 370 µg NAP/L, but not the higher or lower NAP 
exposures, EDV was significantly elevated compared to corresponding control with no 
change in ESV, leading to an increase in Vs (Figure 2.5 A-C). Despite the EDV and Vs change 
in the 370 µg NAP/L group, there was no significant change in ejection fraction (Figure 2.5D). 
In contrast, zebrafish exposed to 37 µg NAP/L showed significantly higher ejection fraction 
despite no significant changes in EDV, ESV or Vs (Figure 2.5 A-D). Zebrafish exposed for 48 
hours to the highest dose of PYR (25µg/L) had significantly reduced ESV compared to 
corresponding control without changes in EDV or SV (Figure 2.5A-C), leading to a greater 
ejection fraction (Figure 2.5D).  
Effects of 48-hour exposure to NAP and PYR in adult zebrafish on heart rate and 
efficiency of cardiac conduction were also assessed from echocardiographic loops. However, 
48-hour NAP exposure at all concentrations in adult zebrafish did not significantly affect 
cardiac output, atrial contractile rate, ventricular contractile rate or the ratio of atrial to 
ventricular rates (Figure 2.6). In contrast, 48-hour aqueous PYR exposure at 2.5 and 25 µg/L 
significantly decreased both atrial and ventricular contractile rates without a change in the 
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ratio of atrial to ventricular rates (Figure 2.6 A, B, C). Despite decreased heart rate in the PYR 
groups, no significant change in cardiac output was observed in these groups compared to 
corresponding control (Figure 2.6D).  
 
 
Figure 2. 5: Echocardiography was used to assess cardiac function with end diastolic 
volume (EDV; A), end systolic volume (ESV; B), stroke volume (C) and ejection fraction (D) 
in adult zebrafish shown following aqueous exposure naphthalene (left; low = 37, med = 
370, high = 3700 µg/L), pyrene (right; low = 0.25, med = 2.5, high = 25 µg/L) or solvent 
control for 48 hours. Data are mean ± SEM of n = 14-16 fish/group. *p < 0.05 in Fisher’s 
LSD after one-way ANOVA compared to the corresponding control group. 
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Figure 2. 6: Atrial contractile rate, ventricular contractile rate, ratio of atrial to ventricular 
rates (AV ratio), and cardiac output of adult zebrafish following 48 hour aqueous exposure 
to naphthalene (left; low = 37, med = 370, high = 3700 µg/L), pyrene (right; low = 0.25, 
med = 2.5, high = 25 µg/L) or solvent control. Data are mean ± SEM of n = 14-16 fish/group. 
*p < 0.05 in Fisher’s LSD after one-way ANOVA compared to the corresponding control 
group. 
 
2.3.5 Energy storage and key metabolizing enzyme gene expression 
 
 The mRNA transcript abundance of two rate limiting aerobic energy metabolizing 
enzymes, citrate synthase (CS) and β-hydroxyacyl coenzyme A dehydrogenase (HOAD) were 
measured as indicators of metabolic dysfunction, then compared to tissue glycogen and 
triglyceride content (Figure 2.7). Glycogen content showed a tendency for dose-dependent 
increase in heart, liver and skeletal muscle from NAP-exposed zebrafish. Only at the highest 
dose was there a significant difference compared to control in the heart (Figure 2.7A). 
However, mRNA level of CS was significantly increased in all three tissues from zebrafish 
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exposed to 370 µg/L NAP as well as in heart from zebrafish exposed to 37 µg/L NAP 
compared to control (Figure 2.7B).  Triglyceride content was elevated in NAP-exposed 
zebrafish heart and skeletal muscle (Figure 2.7D). The mRNA transcript abundance of HOAD 
increased in the heart and skeletal muscle from NAP-exposure (Figure 2.7D).  
For zebrafish exposed to PYR, all tissues showed a tendency to have increased 
glycogen content similar what was observed after NAP exposure, but only liver from 
zebrafish exposed to 2.5 µg PYR/L was significantly increased compared to control (Figure 
2.7A). Also similar to NAP, mRNA level of CS was significantly increased in heart, liver and 
skeletal muscle from zebrafish exposed to 0.25 µg PYR/L compared to the control, CS 
expression in heart from 25 µg PYR/L-exposed zebrafish also showed significant increases 
in CS (Figure 2.7B). Triglyceride levels were unchanged in heart tissue after PYR exposure, 
but were significantly higher in liver and skeletal muscle from zebrafish exposed to 25 µg 
PYR/L compared to control or in skeletal muscle from the 2.5 µg PYR/L group (Figure 2.7C). 
Changes in HOAD transcript abundance were less consistent after PYR exposure across 
tissues. HOAD mRNA level was significantly higher in heart from zebrafish exposed to 2.5 µg 
PYR/L and in skeletal muscle from zebrafish exposed to 25 µg PYR/L compared to 
corresponding control (Figure 2.7D). In contrast, all three concentrations of PYR caused 
significant decreases in HOAD mRNA levels in liver compared to control (Figure 2.7D).  
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Figure 2. 7: Glycogen (A) and triglyceride (C) tissue content as well as mRNA levels  (fold 
change relative to control) of citrate synthase (CS;  B) and β-hydroxyacyl coenzyme A 
dehydrogenase (HOAD; D) in heart, liver skeletal muscle after aqueous exposure to 
naphthalene (left;  low = 37, med = 370, high = 3700 µg/L), pyrene (right; low = 0.25, med = 
2.5, high = 25 µg/L) or solvent control for 48 hours. Data are mean ± SEM. For energy 
storage, heart and liver samples are pooled (n=2 hearts or livers/pooled sample) for a total 
of n=3-5/treatment group, n=10 fish/treatment for mRNA levels. *p < 0.05 in Fisher’s LSD 
after one-way ANOVA compared to the corresponding control group. 
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2.3.6 Gene expression of CYP1A and antioxidant enzymes 
Heart and skeletal from adult zebrafish aqueously exposed to 37 µg NAP/L had 
significantly upregulated CYP1A gene expression as well as in skeletal muscle from zebrafish 
exposed to 370 µg NAP/L compared to corresponding controls (Figure 2.8A). However, in 
liver, CYP1A expression was unexpectedly significantly decreased in zebrafish exposed to all 
concentrations of NAP, but achieved significance for the 370 µg NAP/L (Figure 2.8A).  A 
similar pattern of change in response to NAP was observed for GSR and SOD expression. 
Specifically, heart and skeletal muscle from zebrafish exposed to 370 µg NAP/L showed 
significant increases in both GSR and SOD mRNA levels compared to corresponding controls, 
while NAP was without any significant effect on GSR or SOD expression in liver (Figure 2.8 
B, C).  
After 48-hour exposure in adult zebrafish to all concentrations of PYR tested, both 
cardiac and liver CYP1A mRNA transcript abundance was significantly decreased, while no 
change was observed in skeletal muscle CYP1A (Figure 2.8A). Changes in antioxidant 
enzymes followed a different pattern than CYP1A after PYR exposure. All three tissues 
(heart, liver and skeletal muscle) from zebrafish exposed to 0.25 µg PYR/L group compared 
to corresponding control had significantly increased GSR expression (Figure 2.8B). A similar 
increase in cardiac and hepatic SOD mRNA transcript levels was observed in the same 0.25 
µg PYR/L group, as well as heart from the 25 µg PYR/L-exposed zebrafish compared to 
corresponding controls (Figure 2.8C). However, no significant changes were observed for 
SOD expression at any PYR concentration in skeletal muscle (Figure 2.8C).  
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Figure 2. 8: mRNA levels of cytochrome P450 1A (CYP1A; A), glutathione-S-reductase 
(GSR; B) and superoxide dismutase (SOD; C) in adult zebrafish heart, liver and skeletal 
muscle following aqueous exposure to naphthalene (left; NAP; low = 37, med = 370, high = 
3700 µg/L), pyrene (right; PYR;  low = 0.25, med = 2.5, high = 25 µg/L)or solvent control 
for 48 hours. Data are mean ± SEM of n = 10 fish/group. *p < 0.05 in Fisher’s LSD after one-
way ANOVA compared to the corresponding control group. 
 
2.4 Discussion 
2.4.1 Summary of key findings 
 
In this study, we evaluated the cardiorespiratory and metabolic effects of acute 
aqueous exposure to NAP and PYR in adult zebrafish as well as examining markers of two 
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key pathways for toxicity, CYP1A and antioxidant enzyme induction. The most prominent 
findings of the current study were that NAP and PYR demonstrated notable differences in 
cardiovascular and metabolic effects on adult zebrafish from each other and from BaP. Both 
PAHs of interest had little to no effects on metabolism, as indicated by SMR, AMR and aerobic 
scope. More importantly, neither NAP nor PYR had any effect on swimming endurance, as 
indicated by 𝑈𝑐𝑟𝑖𝑡. Cardiac effects of acute NAP exposure were to increase filling of the heart 
during diastole and increase stroke volume, while PYR instead slowed cardiac pacemakers 
to lower heart rate. Overall, both NAP and PYR tended to increase glycogen and triglyceride 
levels in heart, liver and skeletal muscle, along with increased mRNA levels of CS, a rate-
limiting enzyme. Fatty acid catabolism was also upregulated in cardiac and skeletal muscle 
tissue, as indicated by increased HOAD mRNA levels, in zebrafish exposed to both NAP and 
PYR. However, PYR caused HOAD transcript abundance in the liver to decrease instead. 
Potential mechanisms of toxicity for NAP and PYR could be through AhR activation or 
through increased oxidative stress. To this end, CYP1A mRNA levels was increased in cardiac 
and skeletal muscle, but was instead decreased in liver compared to control after NAP 
exposure. In contrast, PYR showed no ability to increase mRNA levels in any of the tissues 
examined and in fact caused a significant decrease in CYP1A levels in liver and heart instead. 
Finally, both NAP and PYR tended to increase mRNA transcript abundance of SOD and GSR 
in the three tissues examined, suggesting the antioxidant response was activated by both 
PAHs. 
2.4.2 NAP and PYR body burdens 
The levels of NAP and PYR detected in zebrafish in our current study are substantially 
lower than levels detect in fish found in contaminated environments and more in line with 
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reference or control fish (Kalf et al., 1997; Mcdonald et al., 1995; Rainio et al., 1986). This 
study failed to detect any change in NAP or PYR parent compound body burden after 48-
hour exposure in adult zebrafish. It should be noted that the current study did not examine 
metabolites and rapid metabolism of the parent compound is the likely explanation for this 
failure to observe an increase in PAH body burden. In support of this, previous studies in 
various aquatic species have reported that NAP is biotransformed into two 
monohydroxylated naphthalene metabolites (Pulster et al., 2017) or reactive metabolites; 
naphthalene 1,2-oxide and sulphate, glucuronide and GSH conjugates (Krahn et al., 1980). In 
fact, NAP demonstrated a higher biotransformation and preferential metabolism relative to 
phenanthrene (Pulster et al., 2017). Based on previous studies in other aquatic species, PYR 
was also likely rapidly metabolized into pyrene-glucuronide and pyrene-sulfate (Ikenaka et 
al., 2013), or1-hydroxypyrene (Oliveira et al., 2012; Vuontisjärvi et al., 2004). Therefore, 
body burdens after PAH exposure would ideally be determined by the quantification of 
metabolites (Aas et al., 2000; Budzinski et al., 2004; Oliveira et al., 2012), but technical 
difficulty in setting up HPLC techniques to quantify the numerous metabolites precluded 
their measurement in the current study. Since both NAP and PYR exerted observable 
biological effects in the current study despite no change in NAP or PYR body burdens, both 
PAHs must have been bioaccumulated in the adult zebrafish over the 48 hours of exposure, 
but were metabolized by time of sampling for HPLC analysis for parent compounds.   
2.4.3 Swimming performance & metabolic rates 
Swimming performance is critical to the success of both an individual fish and the 
entire fish population (Claireaux et al., 2006; Oliveira et al., 2012). While the current study 
found no effect of NAP exposure on zebrafish swim performance or metabolic rates, other 
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studies reported NAP increased oxygen consumption and metabolic rate in juvenile Florida 
Pompanos (Trachinotus carolinus; dos Santos et al., 2006). Conversely, the current study 
found PYR increased zebrafish active metabolic rate with no change in swim endurance, 
while another previous study reported Pomatoschistus microps acutely exposed to PYR (96h) 
could not resist water flow and covered a shorter swim distance (Oliveira et al., 2012). On 
the other hand, the more toxic PAH, BaP, was found to increase metabolic rate in adult 
zebrafish after acute exposure, but with no change in swimming endurance (Gerger & Weber, 
2015). The differences in findings among studies could be due to zebrafish being a relatively 
hardy species that are resilient swimmers compared to other fish species. Taken together, it 
appears most PAHs including NAP, PYR and BaP, either do not affect or tend to increase 
metabolic rate, which would cause PAH-exposed fish to use more energy to perform same 
amount of exercise as unexposed fish. Previous studies examining exposure to a variety of 
toxicants have also reported elevated standard metabolic rate (Gerger et al., 2014; Thomas 
& Janz, 2011), with many of these studies similarly failing to find a change in swim 
performance. This lack of change in 𝑈𝑐𝑟𝑖𝑡 in the current study may be further related to the 
fact that despite some functional changes in the heart, cardiac output remained unchanged 
after either NAP or PYR exposure. These findings after acute exposure to PAHs in adult fish 
disagree with other studies where developmental exposures to crude oil or TCDD found 
persistently higher oxygen consumption, reduced aerobic capacity and lower 𝑈𝑐𝑟𝑖𝑡  in 
surviving adult zebrafish (Hicken et al., 2011; Marit & Weber, 2012). This highlights the high 
sensitivity of embryonic exposure versus acute adult exposure. Developmental exposure to 
PAHs and TCDD likely had sublethal teratogenic effects that persisted in adult surviving fish, 
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making the effects on swim performance greater than that observed after acute exposure in 
adults.  
2.4.4 Cardiac function  
Due to the necessity to use ultrahigh resolution ultrasound or highly invasive 
instruments to measure cardiac function in adult fish, to our knowledge no previous study 
has reported effects of acute NAP or PYR exposure in adult fish. In the current study, 
zebrafish exposed to 370 µg NAP/L had significantly elevated EDV, consistent with higher 
ventricular filling. Starling’s Law states that stroke volume increases in response to 
increasing preload which is the pressure in the venous system that drives filling of the heart 
during diastole (Farrell, 1991). Although increased ventricular elasticity can also increase 
EDV, this seems less likely of an explanation due to the acute (48 h) nature of the NAP 
exposure in the current study. Instead, extensive edema after NAP exposure was noted 
during dissection in the current study, especially with highest exposure and this is consistent 
with known edematous effects of NAP (USEPA, 2003).  While the current study did not 
examine this directly, abdominal edema is known to increase venous pressure and preload 
(Monnet et al., 2016). Despite this increased stroke volume, cardiac output was not 
significantly changed after NAP exposure in adult zebrafish.  
The effects of acute PYR exposure on cardiac function differed markedly from NAP. In 
the current study, PYR significantly decreased the atrial and ventricular contractile rate 
without altering the atrial ventricular ratio, suggesting the primary effect was decreased 
stimulation of the pacemaker cells.  Acute exposure to BaP in adult zebrafish also resulted in 
bradycardia, but was due to AV conduction blockade (decreased AV ratio with no change in 
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atrial rate), suggesting BaP preferentially affects causes arrhythmias by slowing conduction 
through the atrioventricular node (Gerger & Weber, 2015), while PYR affects either the 
pacemaker cells directly to decrease their excitability or increases vagal firing to the 
sinoatrial node. In addition, BaP further impaired cardiac function by reducing ventricular 
filling, stroke volume and decreasing cardiac output (Gerger & Weber, 2015), while NAP and 
PYR both ultimately had no significant effect on cardiac output in the current study.  Previous 
studies reported that zebrafish embryos exposed to PYR or crude oil had abnormal 
contractions, resulting in increased heart rate, decreased EDV, decreased ESV and decreased 
stoke volume, reduce cardiac output and reduced swim performance (Hicken et al., 2011; 
Incardona & Scholz, 2016; Zhang et al., 2012). The observed decrease in ESV after 25 µg 
PYR/L exposure agrees with these previous studies, but the heart rate changes are opposite 
to what we observed in adult fish and cardiac output was ultimately unaffected. Again, 
teratogenic cardiac effects after embryonic exposure were reported (Hicken et al., 2011; 
Incardona & Scholz, 2016), leading to greater cardiac effects than that observed in the 
current study after adult fish exposures. Taken together, it appears that NAP and PYR have 
some cardiac effects after acute exposure in adult fish, but the heart could still compensate 
to preserve cardiac function. Moreover, the NAP or PYR-induced effects after exposure 
during adulthood appear to differ significantly from the more cardiotoxic BaP at any life 
stage in fish. 
2.4.5 Energy stores and metabolizing enzymes 
Liver and skeletal muscle are both important organs for storage and utilization of 
glycogen and triglycerides, whereas the heart is a tissue with high metabolic demand 
(Rajotte & Couture, 2002). Zebrafish prefer to use free fatty acids as their main source of 
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energy, but will switch to glycolytic energy when needed, especially during the anaerobic 
metabolism observed in fish fatigued at the end of a swimming challenge (Dangé, 1986; 
Salmerón, 2018; Thomas & Janz, 2011; Tocher, 2003). If PAHs tend to increase metabolic 
demand, as PYR did in the current study, then one would predict increased utilization of 
triglyceride and glycogen energy stores. However, the current study instead found that acute 
exposure to either NAP or PYR either did not change or caused increased glycogen and 
triglyceride content in heart, liver and skeletal muscle. Moreover, the observed higher CS 
mRNA levels in the current study after NAP and PYR exposure indicates higher oxidative 
capacity in zebrafish that should have again caused more energy stores to be depleted. 
Previous studies reported that adult tilapia (Oreochromis mossambicus) aqueously exposed 
for up to 10 weeks or female rainbow trout injected intraperitoneal with NAP or BaP had 
reduced muscle and liver glycogen reserves along with increased serum lactate, indicating 
NAP caused a switch to glycolytic anaerobic metabolism (Dange & Masurekar, 1982; Tintos 
et al., 2006; 2008). Differences in exposure duration, exposure route and/or species may 
explain the difference in observations among studies.  
Reported effects of PAHs on tissue triglyceride levels may be more consistent. The 
current study found significant increases in triglyceride content in the heart and skeletal 
muscle after NAP, as well as in the liver and skeletal muscle after PYR exposure. This agrees 
with previous studies examining developmental TCDD exposure or 21-day NAP exposure in 
adult zebrafish, both of which reported increases in whole body triglycerides and fatty 
infiltration of the liver, respectively (Chen et al., 2018; Marit & Weber, 2012). In the current 
study, HOAD mRNA transcript abundance was paradoxically increased after both NAP and 
PYR exposure in heart and skeletal muscle, but not liver where hepatic HOAD was instead 
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decreased after PYR exposure. The heart and muscle results agree with a transcriptome 
analysis of hepatic mRNA in adult zebrafish or whole-body mRNA in larval zebrafish after 
PYR exposure where upregulation of genes associated with both fatty acid synthesis and 
branched chain fatty acid β-oxidation were reported (Chen et al., 2018; Goodale et al., 2013). 
However, changes in mRNA levels do not always translate into changes in enzyme activity. 
This may explain why other studies reported that hepatic HOAD enzyme activity is 
unaffected by intraperitoneal injection of NAP or BaP in rainbow trout (Tintos et al., 2006, 
2008). Thus, we can speculate that tissues from zebrafish exposed to NAP and PYR respond 
with fatty acid accumulation, but may be unable to utilize or access the triglyceride stores 
available. Future studies should examine whether the observed changes in mRNA abundance 
of both glycolytic and lipolytic enzymes translate into similar changes in enzyme activity 
after both NAP and PYR exposure. Moreover, studies should also examine genes associated 
with fatty acid and glycogen synthesis since both catabolism and synthesis would influence 
tissue glycogen and triglyceride levels.  
2.4.6 AhR activation and antioxidant response 
The relative potency of PYR at the AhR is substantially weaker than the strongest PAH 
agonist, BaP, and both are orders of magnitude weaker agonists than TCDD (Barron et al., 
2004). On the other hand, NAP reportedly failed to bind to human AhR at the TCDD binding 
site (Sandoz et al., 1998). Upregulation of CYP1A is a well-known marker of AhR activation 
and the liver is generally considered the most important organ in this detoxification 
response (Denison & Nagy, 2003; Marit & Weber, 2012; Prasch et al., 2003). Previous 
mammalian studies reported that PYR does induce small increases in hepatic 
ethoxyresorufin-o-deethylase (EROD) activity, but does this through increased CYP1A2, not 
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CYP1A1, mRNA transcript abundance (Lee et al., 2007; Shimada & Fujii-Kuriyama, 2004). 
The regulation of CYP1A2 expression by PYR may be through an AhR-independent 
mechanism involving the hepatic constitutive androstane receptor (Lee et al., 2007). In 
contrast, BaP caused a much greater induction in EROD activity as well as increased CYP1A1 
gene expression in an AhR-dependent manner (Shimada & Fujii-Kuriyama, 2004), while NAP 
failed to change mammalian EROD activity or CYP1A1/2 expression (Sandoz et al., 1998). 
The AhR is known to be different in fish compared to mammals, with most toxicity 
thought to be mediated by AhR2 in fish (Prasch et al., 2003), while AhR1 was thought to be 
unresponsive to TCDD-mediated toxicity (Prasch et al., 2003; Ulin et al., 2018). Based on this, 
it would be expected that differences in CYP1A responsiveness to PYR versus NAP should 
also differ between mammals and fish. In Nile tilapia (Oreochromus niloticus), hepatic EROD 
was reported to be strongly induced by four-ringed PAHs such as PYR, while two-ringed 
PAHs such as naphthalene instead decreased EROD activity (Pathiratne & Hemachandra, 
2010). Also, in zebrafish at all life stages, BaP has been previously reported to cause 
significant induction of CYP1A mRNA (Bugiak & Weber, 2009; Fang et al., 2015; Gerger & 
Weber, 2015). Other studies reported fish toxicity from PYR was linked to AhR activation 
and CYP1A induction (Hendon et al., 2008; Incardona et al., 2005; 2004). Therefore, it was 
surprising in the current study that NAP, but not PYR, appeared to activate the AhR 
(increased CYP1A mRNA levels) in cardiac and skeletal muscle. In fact, CYP1A expression 
decreased in heart and liver from PYR-exposed zebrafish in the current study. PYR has been 
reported to bind AhR, but only while AhR was in an antagonist, not agonist conformation 
through selective activation of AhR-nongenomic calcium signaling (Brinchmann et al., 2018), 
and failed to upregulate CYP1A gene expression in zebrafish embryos (Zhang et al., 2012). 
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Thus, this new structure-functional evidence that PYR may prefer to antagonize AhR is 
consistent with the observations of decreased CYP1A in heart and liver after PYR exposure 
in the current study. NAP may be similarly antagonizing the AhR in the liver.  A class of non-
coding RNAs, microRNAs (miRNAs), reported to be important cytoplasmic regulators of gene 
expression (Catalanotto et al., 2016), could be degrading CYP1A mRNA prior to translation 
with NAP exposure. NAP could also be affecting the window of time at which peak mRNA 
transcript abundance could have been missed due to the time at which tissues were sampled. 
However, Atlantic salmon hepatic CYP1A mRNA levels increased eightfold six hours after 
intraperitoneal injection of BNF and reached maximum levels 48hr  after injection (14-fold) 
(Grøsvik et al., 1997), evidence CYP1A mRNA levels reach maximum at 48-hours.  
However, we do not currently have an explanation for why NAP appeared to stimulate 
AhR since CYP1A mRNA transcript abundance increased in heart and skeletal muscle from 
NAP-exposed zebrafish in the current study. What may be related is a recent study in 
zebrafish which demonstrated a complex cooperative action between AhR1b and the 
signaling of the antioxidant response system through nuclear factor erythroid-2 (nrf) 
response elements (Ulin et al., 2018). 
On that note, SOD and GSR mRNA transcript abundance was investigated in the 
current study as indicators of activation of the antioxidant response to PYR or NAP. However, 
they are not direct indicators of oxidative stress since they do not measure levels of reactive 
oxygen species.  Overall, there was an increase in expression of SOD, GSR or both in all tissues 
after both NAP and PYR exposure, agreeing with previous studies reporting similar 
elevations in SOD and GSR using NAP-rich diluted bitumen and oil sand process-affected 
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water (He et al., 2012; Madison et al., 2015). In contrast, another previous study reported 
that neither PYR nor NAP had any effect on activity of another antioxidant enzyme, 
glutathione-S-transferase (GST; Pathiratne & Hemachandra, 2010). A recent meta-analysis 
of lab and field studies of PAH-exposed fish concluded that upregulation of antioxidant 
enzymes such as GST, SOD, glutathione peroxidase and GSR was common after most PAH 
exposures (Santana et al., 2018). Although variable responses in mRNA transcript 
abundance among different antioxidant enzymes were noted after PAH exposure in fish, the 
meta-analysis suggested EROD and GST were possible the most reliable biomarkers. 
However, this same meta-analysis suggested GSR also look promising as a biomarker, but 
inadequate studies examining GSR precluded a definitive conclusion (Santana et al., 2018). 
Taken together with the current study, both SOD and GSR may also good indicators of PAH-
mediated toxicity.  
2.4.7 Hormetic effect of NAP exposure  
Hormesis is characterized by stimulation or a beneficial effect at low doses and a toxic 
or inhibitory effect at high doses (Mattson, 2008). Interestingly, it appears that NAP 
exposure to adult zebrafish is characterized by a biphasic dose response effect. 370 µg/L 
NAP significantly increased EDV and SV in the heart, CS transcript abundance in all three 
tissues and CYP1A transcript abundance in the heart and skeletal muscle. However, these 
changes were not seen at the low and highest dose of NAP, indicating a hormetic response to 
NAP exposure. Another possibility could be the full body edema witnessed upon dissection 
with the fish in the highest dose group. Instead of toxicity occurring at a molecular level, the 
entire body is overwhelmed and experiencing a full body toxicity, therefore resulting in a 
lack of increase in the endpoints listed in the highest exposure group.  
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2.5 Conclusion 
In conclusion, due to the rapid transformation into more hydrophilic metabolites for 
excretion, aqueous exposure to NAP and PYR resulted in only trace amounts of the parent 
compound detected after 48 h aqueous exposures (renewal at 24 h) in adult zebrafish. 
Cardiac effects of NAP versus PYR differed from each other and from that previously 
reported for BaP. Overall, both NAP and PYR cardiac effects were compensated and did not 
change cardiac output or produce arrhythmia, suggesting these PAHs are less cardiotoxic to 
acutely exposed adult zebrafish compared to BaP. Overall, both NAP and PYR tended to 
increase glycogen and triglyceride levels in heart, liver and skeletal muscle, along with 
increased mRNA levels of CS and HOAD, rate-limiting enzymes in the citric acid cycle and 
fatty acid catabolism, respectively, in most of these same tissues. Coupled with no changes 
or minor increases in metabolic rates and aerobic scope, with no change in swimming 
endurance, this suggests again that NAP and PYR exposure at 48 h in adult zebrafish is 
starting to potentially affect the fish’s ability to access its energy stores, but has not yet 
affected swimming. This again differs from BaP which exerted greater metabolic toxicity and 
impaired swimming after only 48 h exposure (Gerger & Weber, 2015). Surprisingly, the 
mechanisms of action may involve AhR activation for NAP, but not PYR, although this may 
involve a complex interaction with a common upregulated antioxidant response after 
exposure to both PAHs. In conclusion, acute NAP and PYR exerted cardiorespiratory toxicity, 
metabolic alterations and mechanisms activated had some similarities with BaP, but BaP is 
clearly a stronger AhR agonist and much more toxic than either NAP or PYR. 
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CHAPTER 3: PHARMACOLOGICAL INVESTIGATION OF ACUTE 
NAPHTHALENE AND PYRENE TOXICITY IN ADULT ZEBRAFISH 
(DANIO RERIO). 
 
3 Preface 
The research in this chapter was designed to investigate whether acute naphthalene 
and pyrene in adult zebrafish depends on the relative potency as aryl-hydrocarbon receptor 
agonists and cytochrome P450 inducers are indicative of relative toxicity or whether 
oxidative stress is a better indicator. The author contributions to Chapter 3 of this thesis 
were as follows:  
Chanel Yeung (University of Saskatchewan) performed 100% of all animal experiments, 
collected, processed, and analyzed all samples, performed all statistical analyses, and drafted 
the manuscript. Lynn Weber (University of Saskatchewan) supervised, helped with study 
design, provided scientific input and guidance, and edited the manuscript. Chapter 2 is being 
prepared for submission for publication in Aquatic Toxicology.  
3.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are organic compounds consisting or two 
or more aromatic rings and, are among the most ubiquitous contaminants present in the 
aquatic environment today (Jaward et al., 2012). PAHs are generated through the incomplete 
combustion of organic matter at high temperatures. Natural sources include forest fires and 
volcanic activity. However, the environmental concern is from the anthropogenic sources, 
including oil spills, automotive exhaust and industrial activity (Abdel-Shafy & Mansour, 
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2016; Neff et al., 2005). Previous studies have focused on the representative PAH, benzo-a-
pyrene (BaP), which induces toxicity through binding to the aryl hydrocarbon receptor (AhR; 
Miller & Ramos, 2001). The well characterized response to AhR activation is increased 
transcription/translation of phase one cytochrome P4501A monooxygenase (CYP1A), which 
in turn causes production of reactive oxygen species and stimulation of the antioxidant 
system (Nebert et al., 2000; Thirman et al., 1994). The reactive BaP metabolites are 
mutagenic and cytotoxic, in addition to their ability to produce oxidative stress (U.S. EPA., 
2017). When a ligand binds to the AhR, there is an upregulation of phase I and II metabolic 
enzymes, ranging from CYPs, aldehyde dehydrogenase 3, NADPH quinone oxidoreductase, 
glutathione S-transferase and UDP-glucuronosyltransferases (Brown, Clark, Garner, & Di 
Giulio, 2016; Denison & Nagy, 2003; Nebert et al., 2000). Anthropogenic ligands such as 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polychlorinated dibenzo-p-dioxins, 
dibenzofurans, and biphenyls, and several PAHs have been heavily studied and are known 
to bind to the AhR and induce AhR dependent gene expression (Brown et al., 2016; Kafafi et 
al., 1993; Waller & Mckinney, 1995). However, some PAHs or their metabolites may cause 
oxidative stress in an AhR-independent manner (Guigal et al., 2000; Raha et al., 1995).  
Previous studies have determined the relative potency of PAHs as AhR agonists in fish 
compared to TCDD. Generally, they found that two and three ring unsubstituted PAHs, such 
as NAP, were largely inactive at the AhR in fish. In contrast, the highest potency PAHs had 4-
6 aromatic rings with an exposed bay region, similar to PYR (Barron et al., 2004; Sandoz et 
al., 1998). Thus, PYR will be studied in this thesis because although it is predicted to act 
largely via AhR activation, knowledge of its mechanism of toxicity is limited compared to that 
of BaP. Despite NAP being reported to be inactive in fish (Barron et al., 2004), in a study 
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analyzing 48 different crude oils from around the world, NAP was present in the highest 
concentration in all 48 samples (Kerr & Melton, 1999). Important detoxification antioxidant 
enzymes, superoxide dismutase (SOD) and glutathione reductase (GSR) (Kim & Lee, 1997; 
Miller & Ramos, 2001) have been shown to be protective against oxidative stress and BaP 
toxicity, therefore will be measured in this study.  
Zebrafish prefer using free fatty acid metabolism rather than carbohydrate or protein 
metabolism (Dangé, 1986; Salmerón, 2018; Thomas & Janz, 2011; Tocher, 2003). The rate 
limiting enzyme in β-oxidation is 3-hydroxacyl-CoA dehydrogenase (HOAD), is responsible 
for the catalysis of acyl-CoA into acetyl-CoA (López-Patiño et al., 2014), and is a biomarker 
of β-oxidation capacity.  HOAD mRNA levels will be compared to triglyceride levels and 
lipoprotein lipase (LPL) mRNA levels. LPL is responsible for hydrolyzing triglycerides into 
free fatty acids, allowing them to be imported from plasma into cells or from cellular lipid 
stores for use in aerobic metabolism (Rajotte & Couture, 2002; Salmerón, 2018). Aerobic 
metabolism of both glucose liberated from glycogen and fatty acids occurs via the citric acid 
cycle to generate ATP, with citrate synthase (CS) as the rate limiting enzyme (Krebs, 1970).  
Developmental exposure to PAHs in various aquatic species consistently 
demonstrated an effect on heart rate, arrhythmias and impaired contractility (Collier et al., 
2013; Incardona et al., 2009; Incardona & Scholz, 2017; Sørhus et al., 2016). Acute BaP 
exposure in adult zebrafish has also been reported to have negative effects on cardiovascular 
function, namely arrhythmia (atrioventricular conduction blockade), bradycardia and 
reduced cardiac output reported (Gerger & Weber, 2015). PAH mixtures derived from crude 
oil or individual tricyclic PAHs have been reported to have similar toxicities (Incardona et 
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al., 2015). Low level PYR is cardiotoxic to zebrafish embryos, changing heart morphology 
similar to that described for the potent AhR agonist TCDD (Incardona et al., 2004; Zhang et 
al., 2012). Developmental PYR exposure caused altered cardiac function (elevated heart rate, 
but decreasing end diastolic, end systolic, and stroke volumes) in larval fish, without a 
change in CYP1A mRNA expression (Zhang et al., 2012). Conversely, developmental 
exposure of zebrafish larvae to NAP, induced mild bradycardia and edema, without the 
profound teratogenic effects on the heart (Incardona et al., 2004). This difference in 
developmental cardiotoxicity between BaP, NAP and PYR could be related to differences in 
affinity for the AhR (Barron et al., 2004), but could also be related to differences in other 
potentially AhR-independent mechanisms of toxicity such as oxidative stress. Moreover, 
whether these same differences in toxicity would be evident in adult fish acutely exposed to 
NAP or PYR compared to known developmental BaP cardiorespiratory toxicity is unclear.  
The purpose of this study is to investigate whether relative potency as AhR agonists 
and CYP1A inducers are indicative of relative toxicity or whether oxidative stress is a better 
indicator.  This can be studied by inhibiting these three endpoints pharmacologically and 
looking at the overall effects on NAP and PYR exposure to zebrafish. From previous studies 
done in our lab (Chapter 2 of this thesis), the concentrations chosen for this co-exposure 
were sub-maximal, but produced consistent changes in gene expression, without major 
cardiac function effects (370µg NAP/L; 2.5µg PYR/L). Adult zebrafish were exposed to each 
PAH, alone or in combination with three antagonistic treatments for 48 hours. To determine 
if cardiometabolic process were dependent of AhR stimulation, a potent AhR antagonist that 
does not stimulate AhR dependent transcription, CH-223191 (3334 µg/L), was used ( Kim et 
al., 2006; Ko & Shin, 2012). Fluoranthene (FL; 500 µg/L) is a PAH, but is also a known CYP1A 
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inhibitor (Brown et al., 2014), while Tempol (4-hydroxy-TEMPOL; 172 µg/L) is a known 
antioxidant scavenger of free radicals (Chatterjee et al., 2000; Epperly et al., 2012). After 48-
hour exposure, fish underwent high frequency cardiac ultrasound technology to measure 
cardiac function. Quantitative reverse transcription PCR (qRT-PCR) was then used to 
quantify mRNA transcript abundance of important metabolic enzymes (CS, HOAD, LPL), a 
biomarker of AhR activation (CYP1A), and indicators of activation of the antioxidant 
response cytochrome (glutathione-S-reductase, GSR and superoxide dismutase, SOD) in 
excised heart, liver and skeletal muscle. Finally, changes in triglyceride and glycogen levels 
were measured in the same tissues as indicators of energy storage. 
3.2 Materials and Methods  
3.2.1 Test compounds 
 Naphthalene (NAP), Pyrene (PYR), dimethyl sulfoxide (DMSO), ethyl 3 
aminobenzoate methanesulfonate (MS-222), fluoranthene (FL), CH-223191 and tempol 
were all purchased from Sigma-Aldrich (Oakville, ON, Canada).  
3.2.2 Test species 
Adult zebrafish were obtained from university colonies and acclimated in 30-L 
holding tanks with particulate, charcoal and ammonia biofilters for a minimum of two weeks 
prior to experiments. Zebrafish were kept on a 14-hour light and 10-hour dark photoperiod. 
Clean, dechlorinated, aerated municipal water was maintained at 27 ± 1 °C with 80% water 
change performed weekly during basic maintenance. Zebrafish were fed twice a day with 
Nutrafin basic flake food (Hagen Inc., Montreal, QC, Canada), with the exception of the last 
24h of exposure or during swim performance or cardiac function testing (Gerger et al., 2014; 
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Gerger & Weber, 2015). Experiments were conducted according to procedures approved by 
the University of Saskatchewan Animal Care and Use committee according to the Canadian 
Council on Animal Care guidelines. 
3.2.3 Aqueous exposure 
Experiments were performed in clean, dechlorinated, aerated municipal water with 
PAHs dissolved in DMSO (0.05% concentration in exposure water) using static renewal 
conditions.  Adult zebrafish (0.3-0.8g) were randomly selected from holding tanks, placed in 
static aerated glass beakers (4 fish/1 L beaker) containing vehicle control (0.05% DMSO),  
PYR (2.5 µg/L) or NAP (370 µg/L) alone, or co-exposed with either 500 µg/L fluoranthene 
(FL), 3333.9 µg/L CH-223191 or 172.2 µg/L Tempol dissolved in 28°C water for 48 hour 
(renewal at 24 hours). Test concentrations were chosen on the basis of the results of our 
previous study. Pharmacological antagonist concentrations were based on previous studies 
(Brown et al., 2014; Epperly et al., 2012; Ko & Shin, 2012). After 48-hour exposure, fish were 
used for cardiac ultrasound (n = 16/treatment). After ultrasound, heart, liver and skeletal 
muscle from a portion of the zebrafish were stored at -80C for triglyceride and glycogen 
analyses or in RNAlater until use for mRNA levels of CYP1A, CS, HOAD, GSR, LPL and SOD.  
3.2.4 In vivo high frequency cardiovascular ultrasound 
After 48 hour exposure, physiological changes to cardiac function were measured 
using a VEVO 3100 high frequency ultrasound machine (VisualSonics, Markham, ON Canada) 
equipped with B-mode imaging, pulsed-wave Doppler, colour flow Doppler and tissue 
Doppler according to methods adapted from rodents (VisualSonics, 2008) and previously 
described in zebrafish (Gerger et al., 2014; Gerger & Weber, 2015). Zebrafish were 
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anesthetized with Aquacalm (20 mg/L; Oakville, ON, Canada) in clean aerated, dechlorinated 
municipal water in a grooved holding dish, ventral side up, prior to ultrasonography and 
anesthesia is maintained throughout. Using a recirculating water bath with aerated 
anesthetic water, temperature was maintained at 27 ± 0.5 C (the same as housing 
temperature) to prevent temperature-induced effects on cardiac function.  
The short and long-axis views of the ventricle were obtained using an MX 700 
scanhead (30-70 MHz; resolution to 30 µm) in B-mode. Simpson’s rule of disks calculated 
ventricular volume (Mercier et al., 1982; Visualsonics, 2008). The ventricle volume is the 
sum of the cylindrical disks, forming an apical disk shape. Because zebrafish do not have a 
hollow ventricular chamber like mammals do, the cross-sectional areas using traces of the 
outer edges of the ventricle were measured (A1 – A3) at three different levels of the ventricle 
in the short axis view. The height of each ventricle disk was then calculated by measuring 
the ventricular length (L) in the long axis view and dividing by the number of short axis views 
(h=L/3). Volume was calculated using an average of at least three different measurements 
in an individual fish during end-systole and during end-diastole for each measurement. 
𝑉 = (𝐴1 + 𝐴2)ℎ + [(
𝐴3ℎ
2
) + (
𝜋
6ℎ3
)] 
(Mercier et al., 1982) 
Stroke volume (𝑉𝑠) for each fish was calculated by subtracting end-diastolic volume 
from end-systolic volume. Ventricular and atrial contractile rates were calculated by 
counting individual chamber contractions in 5 second B-mode ultrasound video loops, then 
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converting to beats per minute (BPM). Ventricular heart rate (𝑓𝐻) multiplied by 𝑉𝑠 was used 
to calculate cardiac output (Q).  
𝑄 =  𝑉𝑠 ∗  𝑓𝐻 
Atrioventricular (AV) ratio was used as a measure of the efficiency of electrical 
excitation from the atrium to the ventricle via the atrioventricular (AV) node by dividing the 
atrial heart rate by ventricular heart rate for each individual fish. This value should equal 1.0 
if cardiac electrical conduction is normal. 
𝐴𝑉 𝑟𝑎𝑡𝑖𝑜 =  
𝐴𝑡𝑟𝑖𝑎𝑙 𝑓𝐻 
𝑉𝑒𝑛𝑡𝑟𝑖𝑐𝑢𝑙𝑎𝑟 𝑓𝐻
 
3.2.5 Determination of triglycerides and glycogen storage 
Frozen heart (2 hearts pooled to create one sample), liver (2 livers pooled to create 
one sample) and skeletal muscle (measured from individual fish) samples were weighed, 
homogenized in 0.2M sodium citrate, immediately heated for 5 min at 100C, then stored at 
-80C until assessment for triglyceride and glycogen levels. Briefly, triglycerides were 
determined using a kit (Sigma-Aldrich, Oakville, ON, Canada) based on a lipase and glycerol 
kinase colorimetric assay, which has been previously validated for measuring triglycerides 
in whole fish homogenates in our laboratory (Thomas & Janz, 2011; Weber et al., 2008) and 
glycerol used as a standard. Glycogen was analyzed using an amylase and glucose oxidase-
based colorimetric assay and purified Type IX bovine liver glycogen as a standard, as 
previously described in our group (Weber et al., 2008). 
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3.2.6 Gene expression analysis – Real time fluorescence qRT-PCR  
Quantitative real time polymerase chain reaction (qRT-PCR) for gene expression 
analyses in zebrafish heart (2 heart pooled/sample), liver (2 liver pooled/sample) and 
skeletal muscle (one sample/fish) was examined for three classes of genes in zebrafish tissue 
using methods previously described in Bugiak & Weber, (2009). As an indication of AhR 
activation, CYP1A mRNA levels was measured (Sarasquete & Segner, 2000). To determine 
the effects on metabolism, mRNA levels of rate limiting enzymes for oxidative metabolism, 
CS, or fatty acid oxidation, HOAD, were analyzed (Rajotte and Couture, 2002). Activated anti-
oxidant  responsive genes were also quantified using GSR and SOD mRNA levels (Cossu et al., 
1997). Total RNA was extracted from frozen tissues with TRIzol (Life Technologies 
Burlington, ON, Canada) according to manufacturer specifications. A NanoDrop apparatus 
and software (Thermo Fisher Scientific, Waltham, MA, USA) was used to assess the purity 
and quantity of mRNA. Samples were reverse transcribed into cDNA from total RNA with 
superscript II reverse transcriptase (iScript, Invitrogen, (Quanta Biosciences, Maryland, 
USA) and oligo (dT) primers using the cDNA synthesis kits (BioRad Mississauga, ON, 
Canada). Chromo4 Multi-Color Real-Time PCR detection system (Biorad, Mississauga, ON, 
Canada) was used for qRT-PCR. Glyceraldehyde-3-phosphate dehydrogenase (G3PDH) was 
used as a housekeeping gene and its transcript abundance determined for each run of a gene. 
Primer sequences for cDNA targets, GenBank accession numbers, target genes and their 
efficiencies that were used for real time qRT-PCR (Liu et al., 2013; McClelland et al., 2006; 
Mccurley & Callard, 2008; Tiedke et al., 2013; Uren-Webster et al., 2010). Each sample was 
run in at least 3 different dilution for each primer pair along with the housekeeping gene to 
generate efficiency curves. The method of analysis used to represent the relative mRNA 
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levels was calculated using CT, where the amount of the gene of interest was normalized 
to the amount of G3PDH in that sample as well as to the mean value for the control group 
and data expressed as fold change from control (Bugiak & Weber, 2009).  
 
Table 3. 1. Primer sequences for cCNA targets, genbank accession numbers, target genes 
and their efficiencies that were used for real time qrt-pcr. (Liu et al., 2013; McClelland et al., 
2006; McCurley & Callard, 2008; Tiedke et al., 2013; Uren-webster et al., 2010).   
 
Gene Primer Sequence (5’-3’) Accession 
number 
Efficiency 
(%) 
CYP1A 
 
Forward GCATTACGATACGTTCGATAAGGAC NM131879 114.0 
Reverse GCTCCGAATAGGTCATTGACGAT 
G3PDH Forward AGCACTGTTCATGCCATCAC NM213094 99.5 
Reverse TACTTTGCCTACAGCCTTGG 
CS Forward AGCGCTGCTATGAATGGTCT BC045362 93.3 
Reverse CTGAGGAAGACAGACCCTCG 
LPL Forward CGCAGGAGCAGCAAGATG NM131127 107 
Reverse GTTCAAAGTAGGCATAATGTAGGG 
HOAD Forward CCACAGGACATTCAGTGGTG ZGI TC279717 93.7 
Reverse GTCAGTGCCATGAACGACAG 
GSR Forward ACAGTCAGTGAGGATGATGTGCCAG NM001020554 97.0 
Reverse TAGACCCAAGAGTGGAAAGAATACCAGC 
SOD Forward TATGCAGCTTCATCACAGCAAGCA NM199976 100.0 
Reverse GGTTGTCACATCACCCTTGGCC 
CYP1A = cytochrome P450 1A; G3PDH = Glyceraldehyde-3-phosphate dehydrogenase; CS = 
citrate synthase; HOAD = 3-hydroxacyl-CoA dehydrogenase; GSR = glutathione reductase; 
SOD = superoxide dismutase 
 
3.2.7 Statistical analysis  
Samples sizes (n) indicate either the number of fish/treatment or the number of pooled 
samples analyzed/treatment. Outliers were identified as those values more than two 
68 
 
standard deviations from the mean and were removed, as appropriate. One-way analysis of 
variance (ANOVA) followed by Fisher’s least significant difference (LSD) post hoc test was 
used to determine significant difference among treatment groups for all endpoints 
measured. Gene expression data are expressed as ΔΔCT values, using expression of the 
housekeeping gene (G3PDH) as an internal control, and then normalized to control group 
expression to calculate fold-change in expression with treatment for the genes of interest. 
CYP1A mRNA transcript abundance was log-transformed to achieve normality 
(Kolmogorov-Smirnov test) and homogeneity of variance (Levene’s test). All statistical 
analyses were carried out using SPSS Statistics v19.0 (IBM Corporation, Armonk, NY) and all 
results are presented as mean ± standard error of the mean (SEM). Principal components 
analysis was performed initially using mean values for each of the 10 treatment groups in 
this study for each endpoint in each tissue measured (36 end-points total). Factors were 
reduced to two components and end-points included in the analysis reduced until ≥70% of 
the variance in the data was explained.   
3.3 Results 
3.3.1 Mortalities and morphometrics 
Following aqueous exposure to NAP, PYR and co-exposure with various 
pharmacological antagonists, subsequent cardiovascular ultrasound, there was no 
statistically significant differences in body mass, body length or condition factor among 
exposure groups (Table 3.2). No mortalities were observed in any treatment group. 
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Table 3. 2. Mortalities and morphometrics of adult zebrafish aqueously exposed to solvent 
control, naphthalene (NAP, 370 µg/L) or pyrene (PYR, 2.5 µg/L), alone or in the presence of 
AhR antagonist (CH223191, 3334 µg/L), CYP1A antagonist (FL = fluoranthene, 500 µg/L), 
or free radical scavenger (tempol, 172 µg/L) for 48 h. 
 
Nominal PAH 
Concentration 
Mortalities Body Weight 
(g) 
Body Length 
(cm) 
Condition 
Factor (K) 
NAP 
Solvent control 0 0.30 ± 0.02 3.02 ± 0.04 1.09 ± 0.03 
NAP alone 0 0.27 ± 0.02 2.94 ± 0.05 1.06 ±0.03 
NAP + CH223191 0 0.26 ± 0.02 2.84 ± 0.05 1.13 ± 0.03 
NAP + FL 0 0.25 ± 0.02 2.79 ± 0.05 1.11 ± 0.03 
NAP + TEMPOL 0 0.22 ± 0.02 2.83 ± 0.07 0.96 ± 0.03 
PYR 
Solvent control 0 0.31 ± 0.01 3.01 ± 0.03 1.12 ± 0.03 
PYR alone 0 0.32 ± 0.02 3.04 ± 0.06 1.10 ± 0.20 
PYR + CH223191 0 0.23 ± 0.02 2.82 ± 0.05 1.03 ± 0.08 
PYR + FL 0 0.25 ±0.02 2.81 ± 0.07 1.10 ± 0.03 
PYR + TEMPOL 0 0.31 ±0.02 3.02 ± 0.07 1.10 ± 0.03 
Data are mean ± SEM with n = 20/group for morphometrics; n=4 replicate beakers/group 
for mortalities. Condition factor (K) = (weight (100/length3). No significant differences 
among treatment groups were detected for any of the data shown using 1-way ANOVA. 
 
3.3.2 Cardiovascular ultrasound analysis  
While neither NAP nor PYR alone significantly altered cardiovascular function at the 
moderate exposure levels examined (Figure 3.1), co-exposure of each pharmacological 
antagonist with NAP significantly reduced ventricular filling and lowered end-systolic 
volume to significantly increase ejection fraction compared to untreated control (Figure 3.1).  
Similarly, NAP and PYR by themselves also had no effect on heart rate or cardiac output 
(Figure 3.2), but yet adding CYP1A inhibition to both PAHs increased heart rate, while adding 
an antioxidant suppressed it, leading to a significant decrease in cardiac output in only the 
PYR + tempol group (Figure 3.2). This suggests the antagonists by themselves could have 
affected cardiac function. However, since we did not do singular exposure of each of the 
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pharmacological antagonists, the combination of the antagonist plus PAH could have 
increased the effects of each other.  
 
Figure 3. 1: Echocardiography was used to assess cardiac function with end diastolic 
volume (EDV; A), end systolic volume (ESV; B), stroke volume (C) and ejection fraction (D) 
in adult zebrafish shown following aqueous exposure to solvent control, naphthalene (left; 
370µg/L) or pyrene (right; 2.5 µg/L) alone, or with CH-223191(33334 µg/L), fluoranthene 
(500 µg/L) or tempol (172 µg/L) for 48 hours. Data are mean ± SEM of n = 14-16 
fish/group. * = p < 0.05 in Fisher’s LSD after one-way ANOVA compared to the 
corresponding solvent control group, # = p < 0.05 in Fisher’s LSD after one-way ANOVA 
compared to the corresponding PAH alone group. 
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Figure 3. 2: Atrial contractile rate, ventricular contractile rate, ratio of atrial to ventricular 
rates (AV ratio), and cardiac output in adult zebrafish shown following aqueous exposure 
to solvent control, naphthalene (left; 370µg/L) or pyrene (right; 2.5 µg/L) alone, or with 
CH-223191(3333.9 µg/L), fluoranthene (500 µg/L) or tempol (172.2 µg/L) for 48 hours. 
Data are mean ± SEM of n = 14-16 fish/group. * = p < 0.05 in Fisher’s LSD after one-way 
ANOVA compared to the corresponding solvent control group, # = p < 0.05 in Fisher’s LSD 
after one-way ANOVA compared to the corresponding PAH alone group. 
 
  
3.3.3 Energy storage and metabolizing enzymes 
To examine effects on metabolism, glycogen, triglycerides and qRT-PCR of key 
metabolic genes were measured in heart, liver and skeletal muscle. While NAP and PYR by 
themselves again had little effect on tissue glycogen or triglyceride levels (Figure 3.3), adding 
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AhR or CYP1A inhibitors with these PAHs tended to increase glycogen in most tissues and all 
three inhibitors tended to increase tissue triglycerides. In contrast, NAP exposure by itself 
increased mRNA levels of both citrate synthase (CS) and 3-hydroxacyl-CoA dehydrogenase 
(HOAD) in all tissues, with all three inhibitors tending to reverse this NAP-induced increase 
in most tissues (Figure 3.3). On the other hand, PYR by itself either had no effect or decreased 
CS and HOAD mRNA levels except for HOAD in skeletal muscle where PYR instead increased 
transcript abundance (Figure 3.3). 
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Figure 3. 3: Glycogen (A) and triglyceride (C) tissue content as well as mRNA levels 
quantified using qRT-PCR (expressed as fold change relative to control) of citrate synthase 
(CS;  B) β-hydroxyacyl coenzyme A dehydrogenase (HOAD; D), and lipoprotein lipase (LPL; 
E) in heart, liver skeletal muscle after aqueous exposure to solvent control, naphthalene 
(left; 370µg/L) or pyrene (right; 2.5 µg/L) alone, or with CH-223191(3334 µg/L), 
fluoranthene (500 µg/L) or tempol (172 µg/L) for 48 hours. Data are mean ± SEM of n = 4-
5 pooled samples of heart or liver/group, n = 14-16 skeletal muscle samples/group. * = p < 
0.05 in Fisher’s LSD after one-way ANOVA compared to the corresponding solvent control 
group, # = p < 0.05 in Fisher’s LSD after one-way ANOVA compared to the corresponding 
PAH alone group. 
 
 
3.3.4 Gene Expression of CYP1A and antioxidant enzymes 
 
In heart, CYP1A inhibition was able to reverse the PYR-mediated decrease in CS 
mRNA levels, while no inhibitors were able to reverse this PYR-mediated decrease in CS in 
skeletal muscle (Figure 3.4). The opposite was true for PYR-mediated changes in HOAD 
mRNA level, where all three inhibitors were without effect in the heart, but yet all three 
inhibitors were able to reverse the PYR-mediated increase in skeletal muscle HOAD 
transcript abundance and AhR inhibition was able to reverse the PYR-mediate decrease in 
liver HOAD.  LPL mRNA levels were not significantly altered by either NAP or PYR exposure 
alone, but adding an AhR antagonist to PYR exposure in liver and skeletal muscle caused 
significant increases in lipoprotein lipase (LPL) transcript abundance compared to PYR 
alone (Figure 3.4). In contrast, all three antagonists when combined with NAP in heart 
caused significant decreases in LPL mRNA levels. Similar to what was observed in previous 
studies (Chapter 2 of this thesis), NAP alone caused increased CYP1A transcript abundance 
in several tissues, while PYR alone instead decreased CYP1A mRNA levels. However, the 
three inhibitors reversed the NAP-mediate CYP1A increases only in skeletal muscle, while 
CYP1A inhibition instead potentiated CYP1A transcript abundance with NAP in the heart. 
Moreover, all inhibitors were without effect on PYR-mediated decreases in CYP1A in the 
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heart, but instead reversed the PYR-mediated decrease in CYP1A in liver. Finally, NAP alone 
increased GSR and/or SOD in heart and skeletal muscle, with no clear pattern of effect of the 
three inhibitors. 
 
 
Figure 3. 4: mRNA levels of cytochrome P450 1A (CYP1A; A), glutathione-S-reductase 
(GSR; B) and superoxide dismutase (SOD; C) in adult zebrafish heart, liver and skeletal 
muscle following aqueous exposure to solvent control, naphthalene (left; 370µg/L) or 
pyrene (right; 2.5 µg/L) alone, or with CH-223191(3333.9 µg/L), fluoranthene (500 µg/L) 
or tempol (172.2 µg/L) for 48 hours. Data are mean ± SEM of n = 4-5 pooled samples of 
heart or liver/group, n = 14-16 skeletal muscle samples/group. * = p < 0.05 in Fisher’s LSD 
after one-way ANOVA compared to the corresponding solvent control group, # = p < 0.05 in 
Fisher’s LSD after one-way ANOVA compared to the corresponding PAH alone group. 
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3.3.5 Factor Analyses  
 
A limitation of the study design analyzed using ANOVA analyses after acute NAP and 
PYR exposure in adult zebrafish, alone and with inhibitors, is low power to detect differences 
among treatments due to the large number of treatment groups. This likely led to a high Type 
II error rate and false negatives. In order to explore the data generated in this study in a 
different way, principal components analysis was conducted. The first step in the type of 
factor analysis is regression of each variable against all others. Initial analyses using all 
endpoints measured in this study were narrowed from 36 endpoints to include only those 
endpoints (17 endpoints in the final analysis) that were highly correlated to the top two 
factors to explain 71.69% of the variance (see Table 3.2 for the component loadings). Key 
regression relationships stemming from the first component show that as muscle CYP1A 
mRNA levels increase, so does HOAD, GSR and SOD in both skeletal muscle and cardiac tissue 
(Figure 3.5). All of these variables were also positively related to cardiac AV ratio (Figure 
3.5). In contrast, component 2 was more strongly related to cardiac ejection fraction and 
heart rate (both atrial and ventricular), with these variables showing strong positive 
correlations to cardiac and muscle energy stores (triglycerides and glycogen), as well as liver 
CYP1A levels (Figure 3.6). Finally, the sum of total scores for each of the top 17 variables 
were used to calculate scores for each component and the two scores plotted against each 
other for each treatment group (Figure 3.7). This plot revealed that all PYR groups clustered 
to the left, with the NAP plus inhibitor and control groups clustered near these points (Figure 
3.7). Of note, the PYR alone group clustered most closely to the control groups, while the NAP 
alone group was quite distinct from any of the other treatment groups, located to the far right 
of the graph (Figure 3.7). 
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Table 3. 3. Principal components analysis of cardiac, metabolic, antioxidant and AhR-
related endpoints measured in heart, liver and skeletal muscle after 48 h exposure in adult 
zebrafish to vehicle control, naphthalene (NAP) or pyrene (PYR), alone or in combination 
with an AhR antagonist (CH223191), CYP1A inhibitor (fluoranthene) or an antioxidant 
(Tempol). The top 17 variables explaining the greatest variance were included in the final 
analysis and are listed in descending order along with corresponding component loadings. 
Component loadings represent the strength of correlation of the endpoint to each 
component. Furthermore, relationships of the variables to each other can be inferred 
through their respective relationships to each component. 
 
 Component 1 Component 2 
Total variance explained 44.90% 26.48% 
Variable Component loadings 
Muscle GSR 0.950 0.014 
Muscle SOD 0.930 -0.041 
Muscle CS 0.930 -0.090 
Cardiac HOAD 0.923 -0.176 
Cardiac SOD 0.917 0.095 
Muscle HOAD 0.860 -0.203 
Cardiac GSR 0.830 0.149 
Muscle CYP1A 0.816 -0.368 
AV ratio 0.677 0.591 
Liver CS 0.587 0.514 
Ejection fraction 0.117 0.797 
Cardiac TG 0.048 0.788 
Muscle TG -0.267 0.744 
Liver CYP1A 0.414 0.710 
Cardiac glycogen -0.234 0.706 
Atrial rate -0.073 0.690 
Ventricular rate -0.301 0.592 
AhR = aryl hydrocarbon receptor; GSR = glutathione-S-reductase; SOD = superoxide 
dismutase; CS = citrate synthase; HOAD = 3-hydroxacyl-CoA dehydrogenase; CYP1A = 
cytochrome P450 1A; AV ratio = ratio of atrial to ventricular contractile rates; CS = citrate 
synthase; TG = triglycerides. 
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Figure 3. 5: Linear regressions (p<0.05 for all relationships shown) for variables that were 
strongly related to component 1 of the Principal Components Analysis conducted in this 
study. Cardiac, metabolic, antioxidant and AhR-related endpoints were measured in heart, 
liver and skeletal muscle after 48 h exposure in adult zebrafish to vehicle control (circles), 
naphthalene (NAP, black symbols) or pyrene (PYR, white symbols), alone (inverted 
triangle) or in combination with an AhR antagonist (CH223191, squares), CYP1A inhibitor 
(fluoranthene, diamonds) or an antioxidant (Tempol, triangle). Mean values for each 
treatment are shown as individual points. 
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Figure 3. 6: Linear regressions (p<0.05 for all relationships shown) for variables that were 
strongly related to component 2 of the Principal Components Analysis conducted in this 
study. Cardiac, metabolic, antioxidant and AhR-related endpoints were measured in heart, 
liver and skeletal muscle after 48 h exposure in adult zebrafish to vehicle control (circles), 
naphthalene (NAP, black symbols) or pyrene (PYR, white symbols), alone (inverted 
triangle) or in combination with an AhR antagonist (CH223191, squares), CYP1A inhibitor 
(fluoranthene, diamonds) or an antioxidant (Tempol, triangle). Mean values for each 
treatment are shown as individual points. 
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Figure 3. 7: A plot of factor scores for components 1 versus 2 for each of the treatment 
groups in this study from the Principal Components Analysis. Cardiac, metabolic, 
antioxidant and AhR-related endpoints were measured in heart, liver and skeletal muscle 
after 48 h exposure in adult zebrafish to vehicle control, naphthalene (NAP) or pyrene 
(PYR), alone or in combination with an AhR antagonist (CH223191), CYP1A inhibitor 
(fluoranthene) or an antioxidant (Tempol). 
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3.4 Discussion 
 
3.4.1 Summary of key findings 
 
In this thesis chapter, I evaluated the cardiovascular and metabolic effects of acute 
aqueous exposure NAP and PYR to adult zebrafish as well as examining markers of two key 
pathways for toxicity, CYP1A and antioxidant enzyme induction. This was the first study, to 
our knowledge, to examine the effects of acute NAP and PYR co-exposure with three 
pharmacological antagonists, on important cardiovascular endpoints and metabolism. In 
PCA, the first component was the one that best distinguished NAP and PYR alone groups 
from controls. This component was positively correlated with GSR, SOD and HOAD in cardiac 
and skeletal muscle as well as muscle CYP1A and higher ratio of atrial-ventricular rates, but 
NAP was a clear outlier in strongly increasing all of these endpoints in component 1. The 
second component distinguished among groups treated with the three inhibitors, being 
positively correlated to liver CYP1A, heart rate, ejection fraction and higher energy stores in 
cardiac and muscle tissues. Taken together, both NAP and PYR alone appear to activate a 
defense mechanism through arrhythmia associated with oxidative stress, while AhR 
inhibition, CYP1A inhibition and free radical scavenging all were associated with improved 
cardiac function and higher energy stores.   
3.4.2 Cardiovascular function  
The lack of effect of NAP and PYR at the exposure concentrations used agrees well 
with findings from the previous study (Chapter 2 of this thesis). What was surprising was 
the large magnitude of effect to stimulate heart rate and contractility (ejection fraction) 
when an AhR antagonist, CYP1A inhibitor and/or free radical scavenger were included in 
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exposures. Zebrafish embryos co-exposed to fluoranthene in combination with known weak 
AhR agonists phenanthrene, a three ringed PAH, increased pericardial edema (Brown et al., 
2014), yet singular exposure had no significant difference from the solvent control. Zebrafish 
with CYP1A knockdown also had higher incidences of cardiac abnormalities (Billiard et al., 
2006). A greater than additive cardiac effect was exhibited in zebrafish embryos when binary 
exposed to fluoranthene and α-naphthoflavone (Billiard et al., 2002, 2006; Van Tiem & Di 
Giulio, 2011) through the AhR mediated pathway. Adding a CYP1A inhibitor could 
significantly slow down AhR agonists from being metabolized. This would result in the 
parent compound having an extended half-life, therefore increasing toxicity (Billiard et al., 
2006; Matson et al., 2008; Wassenberg & Di Giulio, 2004). These findings along with finding 
in this study suggest that CYP1A metabolism has protective properties from cardiac defense 
mechanism associated with exposure to a weak AhR ligand.  
Conversely, PYR co-exposure with tempol had the most significant effects on 
zebrafish cardiovascular function, relative to the solvent and PAH control in the current 
study. Tempol, a known scavenger for superoxide anions (Chatterjee et al., 2000; Laight et 
al., 1997) and “SOD mimetic” (Chatterjee et al., 2000; Krishna et al., 1996) has been 
successfully used to reduce oxidative stress-mediated renal injury and dysfunction 
(Chatterjee et al., 2000), as well as reduce myocardial damage caused by acute pancreatitis 
in rats (Marciniak et al., 2016). Despite the evidence that tempol has protective effects in 
rats, when co-exposed with NAP and PYR in zebrafish, cardiovascular function instead 
appeared to be stimulated, based on increased heart rate and ejection fraction. In cardiac 
tissue, endogenous ROS is now known to contribute to normal cell function (i.e. cell 
differentiation, migration, adhesion, senescence, growth and apoptosis (Chen et al., 2012). 
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Endogenous, normal ROS is likely produced by constitutive activity of NADPH oxidase 4 
(NOX4), a highly expressed enzyme in cardiovascular tissues. However, oxidative stress will 
arise when generation exceeds endogenous antioxidant capacity (Sack et al., 2017). The 
endogenous source of ROS production is insensitive to Hsp90 inhibitors and is regulated in 
response to a wide range of stimuli, including various cardiovascular diseases (Chen et al., 
2012). Instead of having a protective affect against oxidative stress induced by the PAHs, 
tempol could be compromising the function of NOX4 in the cardiovascular system by 
scavenging for the endogenous ROS.  
Co-exposure with AhR antagonist, CH223191, had the least significant effects on 
cardiovascular function compared to the other antagonists. This does not correlate with the 
findings of Incardona et al. (2004), who reported that PYR toxicity to zebrafish embryos was 
similar enough to TCDD and that it must act through the AhR pathway. The difference in 
findings is likely due to the early life stage and teratogenic effects of PYR versus adult in the 
current study. Based on observed changes with the AhR antagonist in the current study, it 
strongly suggests that AhR has a role in normal heart function. This is supported by that fact 
that AhR mRNA is highly expressed in the heart (Dolwick et al., 1993). Others have reported 
an endogenous signal of the AhR pathway that plays a crucial role in cardiovascular 
development and function (Zhang, 2011). AhR knockout mice demonstrate cardiac 
hypertrophy, leading to significant reduction in systolic and diastolic aortic pressure, cardiac 
output and stroke volume (Vasquez et al., 2003; Zhang, 2011), further supporting a 
physiological role for AhR in the cardiovascular system, in the absence of toxicants or other 
exogenous ligands.  
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3.4.3 Energy stores  
In fish, their primary source of energy is free fatty acids (Salmerón, 2018). The strong 
positive relationship between increased antioxidant enzyme expression (GSR and SOD) with 
HOAD mRNA levels suggests that genes associated with the antioxidant response may also 
be needed for lipid mobilization in fish. Yang et al. (2006) found a positive correlation 
between total antioxidant capacity and LPL activity in rats fed a high fat diet.  While LPL was 
largely unaffected by any treatment and did not appear as an important factor in PCA in the 
current study, HOAD transcript abundance in cardiac and muscle was highly affected, 
particularly by NAP, not PYR. However, PYR was previously reported to increase blood 
glucose and triglycerides in the common carp, suggesting PYR can act similar to NAP at a 
suitable dose or in different fish species (Shirdel et al., 2016). This relationship between lipid 
and glycogen metabolism with ROS needs to be further explored to see if NOX or other 
enzymes controlling ROS directly regulate energy metabolism in fish or are merely 
correlated.    
HOAD is a key mitochondrial enzyme involved in β-oxidation of fatty acids (Rajotte & 
Couture, 2002). In our present study, there is a high correlation between NAP co-exposure 
and pharmacological antagonists increasing HOAD mRNA levels, muscular CYP1A mRNA 
levels and the antioxidant response in the heart and muscle. Further examination of the PCA 
analysis revealed that adding the three inhibitors with NAP, the three treatment groups 
clustered together closer towards control treatments relative to NAP alone treatment 
(Figure 3.7). If HOAD mRNA translated into HOAD protein, we would have also expected 
proportional decrease in triglyceride content. However, triglyceride content either remained 
unchanged or increased and was not considered in component one. Therefore, it appears 
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that lipid metabolism (i.e. HOAD) is likely influenced by ROS and the antioxidant response. 
Previous studies have shown that negative regulators of NOX expression, the peroxisome 
proliferator-activated receptor (PPAR) family, play a critical role in the expression of genes 
involved in energy homeostasis, including triglyceride metabolism, fatty acid handling and 
storage (Plutzky, 2011). PPARs are also directly involved with inflammatory and vascular 
response in endothelial and vascular smooth muscle cells, processes that also involve ROS 
production (Manea et al., 2015). Thus, it is possible that the pharmacological antagonists 
along with NAP exposure could be disrupting fatty acid metabolism by targeting PPARs and 
should be explored in future experiments.  
3.4.4 Gene expression of CYP1A, key metabolizing and antioxidant enzymes 
Activation of the AhR activation is often assumed to be indicated by the upregulation 
of CYP1A since its magnitude increase tends to be largest after AhR agonist exposure among 
liver enzymes during the detoxification response (Denison & Nagy, 2003; Marit & Weber, 
2012; Prasch et al., 2003). The known AhR antagonist, BaP causes a large induction in EROD 
activity, a biomarker for chemical exposure (Whyte et al., 2000) as well as increased CYP1A1 
gene expression in an AhR-dependent manner (Shimada & Fujii-Kuriyama, 2004). BaP has 
also been previously reported to cause significant induction of CYP1A mRNA in zebrafish at 
all life stages (Bugiak & Weber, 2009; Fang et al., 2015; Gerger & Weber, 2015). However, 
NAP has been reported to have no effect on EROD activity or CYP1A1/2 expression in 
mammals (Sandoz et al., 1998). AhR-regulated enzymes also did not contribute significantly 
to NAP bioactivation in rodents, but the possibility could not be completely ruled out (Genter 
et al., 2006).  Similar to what was found in our previous study (Chapter 2 of this thesis), NAP 
alone increased CYP1A mRNA levels in heart and skeletal muscle, but not liver. Thus, NAP 
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may be antagonizing the AhR in the liver, but not the higher metabolic tissues in the current 
study. Another explanation could be micro mRNA (miRNA), a class of non-coding RNA. 
miRNAs have been reported as important cytoplasmic regulator of gene expression 
(Catalanotto et al., 2016) and could potentially degrade CYP1A mRNA prior to translation. 
Since tissues were sampled after 48h exposure, the peak window of time mRNA transcript 
abundance could have been missed due to the time at which tissues were sampled at. Ulin et 
al., (2018) reported an interaction between various regulatory pathways, i.e. AhR1b 
antioxidant response system and nuclear factor erythroid-2 (nrf) response elements. 
Zebrafish embryos exposed to TCDD and AhR antagonists induced nrf transcripts, but these 
were significantly decreased upon knockdown of AHR1b (Ulin et al., 2018). NRF2 plays a 
significant role in regulating oxidative stress and is activated when the AhR is bound to 
xenobiotic response element (Ooi et al., 2018). Therefore, it appears nrf2 could be affected 
by NAP exposure, leading to increased CYP1A activation and activation of the antioxidant 
response (increased SOD and GSR mRNA levels). With or without the inhibitors, NAP 
exposure activates the antioxidant response, as indicated through the upregulation of SOD 
and GSR mRNA transcript abundance. The strong association of increased cardiac and 
muscular mRNA levels of GSR and SOD with skeletal muscle CYP1A agrees with previous 
studies reporting similar elevations in SOD and GSR using NAP-rich diluted bitumen and oil 
sand process-affected water (He et al., 2012; Madison et al., 2015). Santana et al. (2018) 
concluded that upregulation of antioxidant enzymes such as GST, SOD, glutathione 
peroxidase and GSR was common after most PAH exposures. However, this study did suggest 
that GSR also look promising as a biomarker, but inadequate studies examining GSR 
precluded a definitive conclusion (Santana et al., 2018). In our current study, both GSR and 
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SOD are highly associated with one another and have a strong relationship with each other. 
Therefore, we can conclude that both are good indicators of the antioxidant response. 
PYR failed to induce CYP1A transcript abundance in the heart, liver and skeletal 
muscles, agreeing with our previous study (Chapter 2 of this thesis). However, when PYR 
was added with CH223191, CYP1A transcript abundance was immediately restored to 
control levels, an unexpected result for an inhibitor of the AhR pathway. Although PYR has 
been reported previously to activate AhR, a previous study in human microvascular 
endothelial and embryonic kidney cells reported a similar lack of change in CYP1A gene 
expression after PYR exposure, but a similar increase in CYP1A after pre-treatment with AhR 
antagonists (Brinchmann et al. 2018). Thus, interaction of AhR with weak PAH agonists in 
the presence of AhR or CYP1A inhibitors/other weak AhR agonists is more complex than 
previously thought and requires further experimentation to delineate the response pathway. 
PYR defence mechanism is highly associated with an upregulation in hepatic CYP1A mRNA 
levels (Figure 3.7), indicating that there is likely tissue specific activation, as reported in 
previous studies (Hendon et al., 2008; Incardona et al., 2005; 2004). However, it was 
surprising in the current study that PYR did not seem to activate the AhR (increased CYP1A 
mRNA levels) in cardiac and skeletal muscle. Previous studies have reported PYR to bind 
AhR, but only while AhR was in an antagonist, not agonist conformation through selective 
activation of AhR-nongenomic calcium signaling (Brinchmann et al., 2018). Similar to 
findings in our study, zebrafish embryos exposed to PYR failed to upregulate CYP1A gene 
expression (Zhang et al., 2012). Mammalian studies have shown PYR to increase EROD 
activity in the liver through increased CYP1A2, not CYP1A1, mRNA expression (Lee et al., 
2007; Shimada & Fujii-Kuriyama, 2004). Therefore, tissue specific responses and CYP1A 
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isoform specific changes need to be clarified. Antioxidant parameters were investigated in 
this present study because oxidative stress might arise during the process of pyrene 
biotransformation (Honkanen et al., 2008; Oliveira et al., 2012).  Goldfish aqueously exposed 
to PYR for 21d determined the mechanism of PYR toxicity originated from activation of redox 
cycling due to ROS production and oxidative stress (Yin et al., 2014). PYR co-exposed with 
CH-223191 and fluoranthene restored changes in GSR levels to those observed with PYR 
alone in heart and skeletal muscle. In contrast, both fluoranthene or tempol resulted in 
elevated GSR levels compared to solvent control, thereby increasing PYR defense 
mechanism. Thus, it appears that high metabolic demand tissues (i.e. heart and skeletal 
muscle) are more sensitive to changes in AhR-mediated pathways (Incardona et al., 2006). 
In contrast, the major detoxifying organ, liver, is more sensitive to ROS (Lee et al., 2007; Yin 
et al., 2014). 
3.5 Conclusion 
PAHs are pervasive contaminants whose toxicity to aquatic species is due to more 
than just BaP. While BaP is the representative PAH whose chemistry and mechanism of 
action are well known, we now know it differs from other important petrogenic PAHs, such 
as NAP and PYR. Previous studies from our lab suggest that NAP may indeed be an AhR 
agonist, resulting in induction of CYP1A mRNA levels. The most interesting finding in this 
study was that pharmacological antagonists of AhR, CYP1A and a free radical scavenging had 
effects of their own on cardiovascular function. This could indicate the need for AhR-
mediated pathways and free radicals for normal cardiovascular function. In conclusion, both 
NAP and PYR defense mechanism does not resemble BaP and all three PAHs cause toxicity 
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through different mechanisms of actions.  Separate from reversing either NAP or PYR effects, 
the pharmacological antagonists were not effective in determining mechanism of action. 
Instead, a complex interaction between AhR, CYP1A, oxidative stress was revealed that 
appears to regulate baseline metabolism and cardiovascular function. Clarification with 
further experimentation is required. 
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CHAPTER 4: GENERAL DISCUSSION 
4.1 Major conclusions of research 
The purpose of this thesis was to determine the cardiorespiratory and metabolic 
toxicity of NAP and PYR to adult zebrafish. From our findings, we determined that both NAP 
and PYR cardiac effects were compensated and did not change cardiac output or produce 
arrhythmia, suggesting these PAHs are less cardiotoxic to acutely exposed adult zebrafish 
compared at BaP. Exposures to NAP and PYR had no significant change on swimming 
endurance and aerobic scope. The lowest PYR concentration increased AMR, but did not alter 
aerobic scope or swimming endurance, which was consistent with NAP exposure. NAP and 
PYR exposure also increased glycogen and triglyceride levels in heart, liver and skeletal 
muscle, along with increased mRNA levels of CS and HOAD, rate-limiting enzymes in the 
citric acid cycle and fatty acid catabolism, respectively, in most of these same tissues. This 
suggests that acute exposures (48h) to NAP and PYR exposure in adult zebrafish inhibit the 
fish’s ability to access energy stores, without affecting swimming, differing from BaP acute 
toxicity (Gerger & Weber, 2015). Surprisingly, NAP and not PYR increased CYP1A mRNA 
transcript abundance in the heart and skeletal muscle, indicating AhR activation. A similarity 
between NAP and PYR defence mechanism in fish is the upregulation of SOD and GSR, 
important antioxidant enzymes, upregulated in response to NAP and PYR. Both PAHs of 
interest cause an imbalance in pro-oxidant and endogenous ROS, resulting in cytotoxicity 
and increases cancer risk from oxidative stress (Nebert et al., 2004; Rengarajan et al., 2015). 
Although GSR expression has been reported to be a poor biomarker for the antioxidant 
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response (Santana et al., 2018), from our findings its clear that oxidative stress plays a role 
in NAP and PYR defence mechanism. 
Due to its chemistry, NAP is assumed to have a weaker affinity to the AhR than PYR 
(Barron et al., 2004). The results of our second chapter determined NAP may indeed be an 
AhR agonist, resulting in induction of CYP1 mRNA levels. With the addition of 
pharmacological antagonists, blocking various points of the AhR dependent pathway, we 
attempted to determine NAP and PYR mechanism of action, however discovered that toxicity 
of these PAHs is more complex than a linear pathway. The pharmacological antagonists could 
be causing an effect of their own on cardiovascular function. This is evidence that normal 
cardiovascular function may involve the AhR-mediated pathway and free radicals (Zhang, 
2011). NAP and PYR binary exposures with pharmacological inhibitors reversed HOAD 
levels in high metabolically demanding tissues. Separate from reversing either NAP or PYR 
effects, the pharmacological antagonists were not effective in determining mechanism of 
action. Principal components analysis (PCA) was performed to determine response patterns 
and relationships among the end-points (17 endpoints in the final analysis). PCA revealed 
highly correlated to the top two factors to explain 71.69% of the variance. The first 
component was the one that best distinguished NAP and PYR alone groups from controls 
showed that as muscle CYP1A mRNA transcript abundance increases, so does HOAD, GSR 
and SOD in both skeletal muscle and cardiac. All of these variables were also positively 
related to cardiac AV ratio. In contrast, the second component distinguished among groups 
treated with the three inhibitors, strongly related to cardiac ejection fraction, atrial and 
ventricular heart rate, with these variables showing strong positive correlations to cardiac 
and muscle energy stores (triglycerides and glycogen), as well as liver CYP1A mRNA levels. 
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Although we were unable to determine the defence mechanism of NAP and PYR in adult 
zebrafish, we were able to support the complex interaction between normal cardiac and 
metabolic control with oxidative stress and AhR signalling. NAP toxicity is heavily associated 
with CYP1A mRNA induction in skeletal muscles, resulting in greater HOAD, GSR, SOD mRNA 
levels in highly metabolic tissues. This associates with a positive relationship with AV-ratio. 
Whereas PYR toxicity affects ejection fraction and heart rate, increasing energy stores in 
skeletal muscles and heart, as well as hepatic CYP1A mRNA levels.  In conclusion, acute NAP 
and PYR exerted cardiorespiratory toxicity, metabolic alterations and mechanisms activated 
had some similarities with BaP, but BaP is clearly a stronger AhR agonist and much more 
toxic than either NAP or PYR.  
4.2 Strengths and limitations of research  
 The present study successfully evaluated the acute cardiorespiratory and metabolic 
acute toxicity of NAP and PYR to adult zebrafish. This work has been the first to characterize 
the effects of NAP and PYR exposure on adult zebrafish cardiac function in vivo using high 
frequency ultrasound techniques, coupled with swim tunnel respirometry from a 
toxicological perspective. These techniques coupled with changes of rate limiting enzymes 
(CS and HOAD), antioxidant response (GSR and SOD) and CYP1A mRNA levels using qRT-
PCR in three different tissue types.  
One limitation of this study that could have improved the present work was the body 
burden analysis. We did not evaluate potential metabolites in addition to parent compound.  
Due to the rapid transformation into more hydrophilic metabolites for excretion, aqueous 
exposure to NAP and PYR resulted in only trace amounts of the parent compound detected 
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after 48 h aqueous exposures (renewal at 24 h) in adult zebrafish. Determining NAP and PYR 
metabolites would have aided in quantifying the biotransformation of the PAHs of interest 
undergoing in adult zebrafish. Water sample should have also been taken to analyze the 
concentration of NAP and PYR present in the water, and to quantify the amount actually 
taken up by zebrafish. 
In measuring changes in key metabolizing enzymes, instead of using CS, glycogen 
phosphorylase, a rate limiting enzyme in glycogen metabolism (Agius, 2015), would have 
been a better indicator since it is specific to aerobic metabolism compared to CS. In our study 
we used one of the most commonly used housekeeping gene, G3PDH. Unfortunately, G3PDH 
also plays an important a role in glycolysis, therefore it may not have been the best choice 
when determining treatments effects on aerobic metabolism. Instead, multiple 
housekeeping genes should have been used. 
The concentrations that we had exposed our fish to were within the range of what is 
found in the ambient environment or what is found in crude oil. Although environmentally 
relevant, the doses were not high enough to alter swimming performance and oxygen 
consumption. It was apparent from our first study, that the highest PYR concentration 
(25µg/L) reduced AMR, without altering any other endpoints. In order to get a more accurate 
change on swimming performance, a more strenuous swim challenge, such as a repeated 
𝑈𝑐𝑟𝑖𝑡 challenge with minimal recovery time in between would have been needed. However, 
the concentrations at which we exposed our fish to were enough to initiate changes in energy 
stores and antioxidant response.  
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 Unfortunately, in the second data chapter, we did not do singular exposures of each 
pharmacological antagonist. Therefore, unable to conclusively determine if the 
cardiovascular and metabolic changes were from the inhibitors or binary exposures. 
However, if we had done the singular exposures, this would have already lowered our power 
to detect any differences among treatment due to the large number of treatment groups. Our 
study design analyzed using ANOVA analyses after acute NAP and PYR exposure in adult 
zebrafish, alone and with inhibitors also lowers the power. Combined with the need to pool 
liver and heart samples for energy store analysis, our power was further lowered. Future 
experiments should use a higher number of samples.  High Type II error and false negatives 
likely occurred. Fortunately, principal components analyse was able to explore the data 
generated in a different way. 
4.3 Concluding statement 
 
In conclusion, the present thesis shown that acute NAP and PYR exposure to adult 
zebrafish differs from each other and from BaP. Both NAP and PYR have some ability be to 
AhR as agonists. It is assumed that NAP affinity to the AhR is significantly less than PYR, 
however our research does not support this assumption. Crude oil is a complex mixture of 
toxicants but many studies have shown that PAHs are the most toxic component to aquatic 
organisms (Incardona, 2017). The largest fraction of PAHs in crude oil are two-ring NAPs, 
which have been reported to produce no developmental toxicity in zebrafish (Incardona et 
al., 2005; 2004) and are poor ligands to the AhR (Barron, et al., 2004). Majority of studies 
done on PAHs have been done on single compounds and on the most potent AhR ligands, 
generally being 4 rings or more. However, in our study, we have found that the volatile two-
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ring PAH, NAP induced CYP1A mRNA levels and not PYR. Although we found no changes in 
swimming performance, extensive edema after high NAP exposure was noted during 
dissection in the current study, consistent with known edematous effects of NAP (USEPA, 
2003). In the event of an oil spill, the highest concentration of NAP could potentially cause 
an entire fish population to undergo full body edema, resulting in a whole-body toxicity. 
Taken together, due to NAP high abundance and evidence for AhR-mediated toxicity, NAP 
found in crude oil should be a greater concern to the aquatic environment should be a greater 
concern.  
Incardona et al., (2006) found that PYR produced developmental toxicity in zebrafish 
by activating the AhR and induce CYP1A expression. However, from our study, adult 
zebrafish toxicity to PYR differs. PYR failed to induce CYP1A in the heart and skeletal muscle, 
yet cardiotoxicity still occurred.  Cardiovascular ultrasound of PYR exposed zebrafish had a 
lower contractile rate without changing AV ratio. Swim tunnel analysis revealed that 0.25 
µg/L PYR exposure to adult zebrafish resulted in a significant increase in AMR. This indicates 
that more energy is needed to perform the same amount of exercise. If an oil spill were to 
occur, fish exposed to PYR would be at a disadvantage because more energy would be 
allocated in order to find prey or swimming away from predators. As for the population as a 
whole, less energy would be used for normal growth, function and reproduction, therefore 
lowering the entire fish populations success.  
While the exact mechanism of toxicity was not explained by this study alone, it is clear 
that cardiovascular and metabolic homeostatic regulation is more complex than expected. 
The pharmacological antagonists used had cardiovascular effects on their own, separate 
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from reversing either NAP or PYR effects. PAH exposure cannot be simplified into a linear, 
singular pathway, often represented by the prototypical PAH, BaP. Future studies should be 
focused on determining the differences in mechanism of PAHs rather than using one PAH to 
represent them all.  
4.4 Future direction 
This study answered questions regarding NAP and PYR acute toxicity in adult 
zebrafish, but there are many questions yet to be answered. The exact mechanism of toxicity 
of NAP and PYR are still unknown. Although based on our PCA analysis, we were able to 
determine that NAP toxicity is more related to oxidative stress and AhR-mediated toxicity 
than PYR, we were not successful in determining the exact pathway of NAP and PYR toxicity. 
Previous studies have shown that embryonic PAH exposure in fish can have negative effects 
on cardiorespiratory effects in adulthood (Hicken et al., 2011). The chronic toxicity of NAP 
and PYR exposure on adult fish has yet to be researched. 
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